1,745 interaction records, searched.

Recommendation

Do NOT combine. Choose one serotonin precursor, not both.

Mechanism

5-HTP bypasses rate-limiting tryptophan hydroxylase to directly flood serotonin synthesis. L-Tryptophan feeds the same pathway upstream. Combined effect causes dangerous serotonin accumulation.

• Turner EH et al. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther. 2006;109(3):325-38.Source linkedPMID
• Fernstrom JD. A Perspective on the Safety of Supplemental Tryptophan Based on Its Metabolic Fates. J Nutr. 2016;146(12):2601S-2608S.Source linkedPMID
• Boyer EW et al. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID

Recommendation

Do NOT combine 5-HTP with SSRIs, SNRIs, MAOIs, or other serotonergic medications unless specifically directed by the prescriber managing the medication.

Mechanism

5-HTP bypasses the rate-limiting tryptophan hydroxylase step and increases serotonin production. SSRIs/SNRIs reduce serotonin reuptake and MAOIs reduce monoamine breakdown, creating additive serotonergic excess.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do NOT combine. Both increase serotonergic activity through different mechanisms.

Mechanism

Hyperforin in St. John's Wort blocks serotonin reuptake. 5-HTP bypasses rate-limiting enzyme to increase serotonin production. Dual mechanism creates dangerous serotonin excess.

• Borrelli F et al. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J. 2009;11(4):710-27.Source linkedPMID
• Singer A et al. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1. J Pharmacol Exp Ther. 1999;290(3):1363-8.Source linkedPMID
• Turner EH et al. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther. 2006;109(3):325-38.Source linkedPMID
• Boyer EW et al. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID

Recommendation

Do not drink alcohol while taking acitretin. If pregnancy is possible, avoid alcohol during treatment and for at least 2 months after stopping acitretin, and follow your prescriber's contraception and pregnancy-testing plan exactly. Tell your prescriber if you drank alcohol while on acitretin.

Mechanism

Ethanol enables ethyl esterification of acitretin to etretinate through an acitretinoyl-CoA intermediate. Etretinate partitions into fat and has a much longer terminal half-life than acitretin, prolonging systemic retinoid exposure and teratogenic potential.

• Larsen FG, Jakobsen P, Knudsen J, Weismann K, Kragballe K, Nielsen-Kudsk F. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. J Invest Dermatol. 1993;100(5):623-627.Source linkedPMID
• Knights KM, Stresser DM, Miners JO, Crespi CL. In vitro metabolism of acitretin by human liver microsomes: evidence of an acitretinoyl-coenzyme A thioester conjugate in the transesterification to etretinate. Biochem Pharmacol. 2000;60(4):507-516.Source linkedPMID

Recommendation

Do not take vitamin A supplements, cod liver oil, or retinoid-containing products while on acitretin unless your dermatologist specifically directs it. Check multivitamin labels for retinol, retinyl palmitate, retinyl acetate, or vitamin A. Seek care promptly for severe headache, vision changes, jaundice, or pregnancy exposure.

Mechanism

Acitretin activates retinoid signaling and produces adverse effects resembling hypervitaminosis A. Exogenous preformed vitamin A adds retinoid receptor substrate and can increase hepatic, lipid, neurologic, mucocutaneous, skeletal, and fetal toxicity.

• Ormerod AD, Campalani E, Goodfield MJ, et al. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010;162(5):952-963.Source linkedPMID
• Kamm JJ. Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids. J Am Acad Dermatol. 1982;6(4 Pt 2 Suppl):652-659.Source linkedPMID

Recommendation

Do not use cocaine while using albuterol. If cocaine exposure occurs, do not keep repeating albuterol for chest tightness without medical assessment, because symptoms may reflect bronchospasm, ischemia, panic, or arrhythmia. Seek emergency care for chest pain, severe shortness of breath, fainting, severe agitation, or a fast or irregular heartbeat.

Mechanism

Albuterol stimulates beta-2 adrenergic receptors and can produce beta-mediated cardiac stimulation and intracellular potassium shift. Cocaine blocks norepinephrine reuptake, increases sympathetic outflow, causes vasoconstriction, and has sodium-channel blocking effects, creating additive arrhythmia and ischemia risk.

• Ahrens RC, Smith GD. Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use. Pharmacotherapy. 1984;4(3):105-121.Source linkedPMID
• Vongpatanasin W, Mansour Y, Chavoshan B, Arbique D, Victor RG. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation. 1999;100(5):497-502.Source linkedPMID
• Billman GE. Cocaine: a review of its toxic actions on cardiac function. Crit Rev Toxicol. 1995;25(2):113-132.Source linkedPMID
• Tashkin DP, Kleerup EC, Koyal SN, Marques JA, Goldman MD. Acute effects of inhaled and i.v. cocaine on airway dynamics. Chest. 1996;110(4):904-910.Source linkedPMID

Recommendation

Do not drink alcohol while taking alprazolam. If you drank recently, avoid non-urgent alprazolam dosing and ask your prescriber or pharmacist for individualized guidance. Seek urgent help for extreme sleepiness, slow breathing, confusion, or inability to wake.

Mechanism

Alprazolam is a positive allosteric modulator of GABA-A receptors. Alcohol also enhances inhibitory GABAergic tone and impairs cortical and brainstem arousal, producing additive CNS depression and psychomotor impairment.

• Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health. 1999;23(1):40-54.Source linkedPMID
• Drummer OH. Benzodiazepines - Effects on Human Performance and Behavior. Forensic Sci Rev. 2002;14(1-2):1-14.Source linkedPMID

Recommendation

Avoid concurrent use if possible. If unavoidable, perform baseline ECG, monitor QTc closely, and discontinue if QTc exceeds 500 ms. Ensure electrolytes (K+, Mg2+) are normal.

Mechanism

Amiodarone blocks multiple cardiac ion channels including hERG potassium channels. Fluoroquinolones also block hERG channels. Additive blockade prolongs cardiac repolarization and QT interval.

• Tisdale JE et al. Drug-induced arrhythmias: a scientific statement from the AHA. Circulation. 2020.Source linkedPMID
• Alves C, Mendes D, Marques FB. Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis.. European Journal of Clinical Pharmacology. 2019.Source linkedPMID

Recommendation

Do not use cocaine while taking amphetamine/dextroamphetamine. If cocaine exposure occurs, do not take extra stimulant doses and avoid exercise or overheating. Seek emergency care for chest pain, fainting, severe headache, severe agitation, shortness of breath, or a racing or irregular heartbeat.

Mechanism

Cocaine blocks dopamine, norepinephrine, and serotonin reuptake and also has sodium-channel blocking effects. Amphetamine/dextroamphetamine increases catecholamine release through DAT and NET, so the combination can produce additive adrenergic stimulation and myocardial oxygen demand.

• Rush CR, Stoops WW, Hays LR. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. Drug Alcohol Depend. 2009;99(1-3):261-271.Source linkedPMID
• Kim ST, Park T. Acute and Chronic Effects of Cocaine on Cardiovascular Health. Int J Mol Sci. 2019;20(3):584.Source linkedPMID

Recommendation

Do not use MDMA while taking amphetamine/dextroamphetamine. Do not redose either substance to chase effects or stay awake. Seek emergency care for high fever, confusion, severe agitation, chest pain, fainting, seizure, severe headache, or a racing or irregular heartbeat.

Mechanism

Amphetamine/dextroamphetamine promotes dopamine and norepinephrine release through DAT and NET. MDMA releases serotonin through SERT and also releases norepinephrine and dopamine, producing overlapping adrenergic stimulation plus hyperthermia risk.

• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID
• Steinkellner T, Freissmuth M, Sitte HH, Montgomery T. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine. Biol Chem. 2011;392(1-2):103-115.Source linkedPMID
• O'Cain PA, Hletko SB, Ogden BA, Varner KJ. Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. Physiol Behav. 2000;70(1-2):141-148.Source linkedPMID

Recommendation

Do not combine nattokinase with apixaban. If you have been taking both, stop the nattokinase and call your prescriber, especially if you notice unusual bruising or bleeding.

Mechanism

Nattokinase, a serine protease from fermented soybeans, directly cleaves fibrin and activates plasmin-mediated fibrinolysis. It also reduces plasma fibrinogen, factor VII, and factor VIII levels. These effects compound apixaban's inhibition of factor Xa.

• Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-9.Source linkedPMID
• Elahi MM, Choi CH, Konda S, Shake JG. Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis. Proc (Bayl Univ Med Cent). 2015;28(1):81-2.Source linkedPMID

Recommendation

Avoid nattokinase while on aspirin, especially if you have a history of stroke, cerebral microbleeds, or uncontrolled hypertension. If you have been taking both, stop the nattokinase and call your prescriber.

Mechanism

Nattokinase directly cleaves fibrin and activates plasmin-mediated fibrinolysis, while reducing fibrinogen and factor VII/VIII. These effects add to aspirin's irreversible COX-1 inhibition of platelet thromboxane A2 production, sharply raising bleeding risk.

• Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-9.Source linkedPMID
• Elahi MM, Choi CH, Konda S, Shake JG. Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis. Proc (Bayl Univ Med Cent). 2015;28(1):81-2.Source linkedPMID

Recommendation

Do NOT combine without transplant specialist supervision. May require immunosuppressant dose reduction.

Mechanism

Berberine inhibits intestinal P-glycoprotein efflux and hepatic CYP3A4 metabolism of cyclosporine/tacrolimus.

• Berberine cyclosporine AUC 34.5% increase in transplant patientsSource linkedPMID
• Berberine drug interaction profile comprehensive reviewSource linkedPMID

Recommendation

Do not infuse IV ceftriaxone with calcium-containing IV solutions, especially in neonates. Oral calcium supplements are generally acceptable but should ideally be spaced from IV ceftriaxone doses. Discuss any IV co-administration with your clinical team.

Mechanism

Ceftriaxone and calcium form insoluble ceftriaxone-calcium salt crystals that can precipitate in the lungs, kidneys, and IV line. Neonates are at highest risk due to immature renal clearance and high relative blood volume per dose.

• Monte SV, Prescott WA, Johnson KK, Kuhman L, Paladino JA. Safety of ceftriaxone sodium at extremes of age. Expert Opin Drug Saf. 2008;7(5):515-23.Source linkedPMID
• Nilsson N, Nezvalova-Henriksen K, Bøtker JP, et al. Co-administration of Intravenous Drugs: Rapidly Troubleshooting the Solid Form Composition of a Precipitate in a Multi-drug Mixture Using On-Site Raman Spectroscopy. Mol Pharm. 2023;20(6):2853-2863.Source linkedPMID

Recommendation

Do NOT take 5-HTP with citalopram.

Mechanism

Citalopram blocks SERT, preventing serotonin reuptake. 5-HTP increases serotonin synthesis. The combination produces dangerous serotonin excess.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Truyens M, Lobatón T, Ferrante M et al.. Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial. Gastroenterology. 2022.Source linkedPMID
• Sutanto CN, Xia X, Heng CW et al.. The impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: A randomized controlled trial. Clinical Nutrition. 2024.Source linkedPMID

Recommendation

Do not take L-tryptophan supplements with citalopram. Food intake of tryptophan is fine; concentrated supplemental doses are the issue.

Mechanism

L-Tryptophan is converted to 5-HTP and then serotonin throughout the body. Citalopram blocks SERT; combined, both inputs raise synaptic serotonin to potentially toxic concentrations.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID
• Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777-98.Source linkedPMID

Recommendation

Do not combine MDMA with citalopram. Wait at least 1-2 weeks after stopping citalopram before any MDMA exposure.

Mechanism

Citalopram occupies SERT, blunting MDMA-induced reverse transport of serotonin. Cumulative serotonergic activity with impaired clearance can trigger serotonin toxicity; concurrent QT prolongation magnifies arrhythmia risk.

• Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013;25(3):193-9.Source linkedPMID
• Beach SR, Kostis WJ, Celano CM, et al. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry. 2014;75(5):e441-9.Source linkedPMID

Recommendation

Do NOT combine St. John's Wort with citalopram.

Mechanism

Both agents block SERT. Combined blockade leads to excessive synaptic serotonin. Additionally, SJW may alter citalopram levels through CYP enzyme induction.

• Lantz MS et al. St. John's wort and antidepressant drug interactions. J Geriatr Psychiatry Neurol. 1999;12(1):7-10.Source linkedPMID

Recommendation

Avoid alcohol while taking clonazepam. Do not drive or operate machinery if any alcohol was used near a clonazepam dose. Seek emergency care for severe confusion, slow breathing, blue lips, or inability to wake.

Mechanism

Clonazepam enhances GABA-A receptor signaling; alcohol also potentiates GABA-A activity and suppresses excitatory NMDA signaling. The overlap increases neuronal inhibition and reduces arousal and ventilatory safety margins.

• Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health. 1999;23(1):40-54.Source linkedPMID
• Ingum J, Bjørnstad S, Mørland J. Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines. Psychopharmacology (Berl). 1992;107(1):11-17.Source linkedPMID

Recommendation

Do not combine nattokinase with clopidogrel. If you have been taking both, stop the nattokinase and contact your prescriber, particularly if you have any history of stroke or unusual bruising or bleeding.

Mechanism

Nattokinase directly cleaves fibrin and activates plasminogen, reducing fibrinogen and factor VII/VIII. These add to clopidogrel's irreversible blockade of platelet P2Y12 receptors.

• Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-9.Source linkedPMID
• Elahi MM, Choi CH, Konda S, Shake JG. Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis. Proc (Bayl Univ Med Cent). 2015;28(1):81-2.Source linkedPMID

Recommendation

Do not combine. This is a dangerous combination associated with sudden cardiac death. If experiencing chest pain, severe agitation, or breathing difficulty, seek emergency medical care immediately.

Mechanism

Hepatic transesterification of cocaine in the presence of ethanol forms cocaethylene, which has a longer half-life than cocaine and potently blocks dopamine reuptake while exerting greater cardiotoxicity and additive sympathetic stimulation.

• Pennings EJ et al. Effects of concurrent use of alcohol and cocaine. Addiction. 2002;97(7):773-83.Source linkedPMID
• Farré M et al. Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther. 1993;266(3):1364-73.Source linkedPMID

Recommendation

Do NOT take St. John's Wort with oral contraceptives. Use alternative contraception (non-hormonal) if taking SJW. Multiple documented cases of unintended pregnancy.

Mechanism

Ethinyl estradiol and progestins (levonorgestrel, norethindrone, etc.) are CYP3A4 substrates. SJW-mediated CYP3A4 induction reduces their levels below effective contraceptive concentrations.

• Hall SD et al. The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther. 2003;74(6):525-535.Source linkedPMID
• Schwarz UI et al. Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. Br J Clin Pharmacol. 2003;55(1):112-113.Source linkedPMID

Recommendation

Avoid nattokinase while taking dabigatran. If you have already combined them, stop nattokinase and contact your prescriber promptly if you notice unusual bruising, black stools, blood in urine, severe headache, or weakness.

Mechanism

Nattokinase directly cleaves fibrin and has been shown to lower fibrinogen, factor VII, and factor VIII. These effects add to dabigatran's direct thrombin inhibition and can weaken hemostasis through separate pathways.

• Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-469.Source linkedPMID
• Hsia CH, et al. Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res. 2009;29(3):190-196.Source linkedPMID

Recommendation

Do not take 5-HTP while using desvenlafaxine. Stop 5-HTP and discuss a washout plan before starting desvenlafaxine. Seek urgent care for fever, muscle rigidity, clonus, severe agitation, or confusion.

Mechanism

5-HTP bypasses tryptophan hydroxylase and is decarboxylated by aromatic L-amino acid decarboxylase to serotonin. Desvenlafaxine inhibits SERT and NET, so increased serotonin synthesis is paired with reduced serotonin reuptake.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Jacobsen JPR, Krystal AD, Krishnan KRR, Caron MG. Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale. Trends Pharmacol Sci. 2016;37(11):933-944.Source linkedPMID
• Sansone RA, Sansone LA. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. Innov Clin Neurosci. 2014;11(3-4):37-42.Source linkedPMID

Recommendation

Do not use L-tryptophan supplements while taking desvenlafaxine. Choose a non-serotonergic sleep or mood support option if needed. If you accidentally combine them, stop the supplement and monitor for agitation, tremor, sweating, diarrhea, fever, or clonus.

Mechanism

L-Tryptophan is converted to 5-HTP and then serotonin, increasing serotonin synthesis capacity. Desvenlafaxine inhibits SERT and NET, decreasing serotonin reuptake while precursor availability is increased.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Young SN. Use of tryptophan in combination with other antidepressant treatments: a review. J Psychiatry Neurosci. 1991;16(5):241-246.Source linkedPMID
• Sansone RA, Sansone LA. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. Innov Clin Neurosci. 2014;11(3-4):37-42.Source linkedPMID

Recommendation

Do not use MDMA while taking desvenlafaxine. Avoid redosing if MDMA effects feel reduced; blunting does not remove toxicity risk. Seek emergency care for high fever, clonus, confusion, severe agitation, chest pain, fainting, or severe headache.

Mechanism

MDMA acts as a substrate at SERT and NET and promotes reverse monoamine transport. Desvenlafaxine inhibits SERT and NET, creating transporter competition and additive serotonergic and adrenergic stress.

• Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology (Berl). 2022;239(6):1945-1976.Source linkedPMID
• Makunts T, Jerome L, Abagyan R, de Boer A. Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database. Front Psychiatry. 2021;12:824288.Source linkedPMID
• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID

Recommendation

Do not combine St. John's Wort with desvenlafaxine. Allow at least a 2-week washout after stopping St. John's Wort before starting or restarting desvenlafaxine unless your prescriber gives a different plan. Avoid other serotonergic substances during the transition.

Mechanism

Hyperforin-containing St. John's Wort inhibits monoamine reuptake and activates pregnane X receptor pathways that induce CYP3A4 and P-glycoprotein. Desvenlafaxine inhibits SERT and NET, so the main concern is additive serotonergic pharmacodynamics.

• Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777-1798.Source linkedPMID
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Fanelli D, Weller G, Liu H. New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations. Neurol Int. 2021;13(4):497-509.Source linkedPMID

Recommendation

Do not drink alcohol while taking diazepam. Avoid driving if you have taken diazepam and consumed alcohol within the same day. Get urgent help if you develop severe drowsiness, confusion, or slow breathing.

Mechanism

Diazepam enhances GABA-A receptor opening frequency, while alcohol enhances inhibitory GABAergic tone and impairs excitatory neurotransmission. Their overlapping pharmacodynamic effects deepen sedation and coordination impairment.

• Palva ES, Linnoila M, Saario I, Mattila MJ. Acute and subacute effects of diazepam on psychomotor skills: interaction with alcohol. Acta Pharmacol Toxicol (Copenh). 1979;45(4):257-264.Source linkedPMID
• Ingum J, Bjørnstad S, Mørland J. Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines. Psychopharmacology (Berl). 1992;107(1):11-17.Source linkedPMID

Recommendation

Do not take L-tryptophan supplements with duloxetine. Food tryptophan is fine; avoid concentrated sleep or mood products containing L-tryptophan. Get urgent help for clonus, high fever, severe restlessness, confusion, or muscle rigidity.

Mechanism

L-Tryptophan increases the pool of serotonin precursor available to serotonergic neurons. Duloxetine inhibits SERT and NET, so increased serotonin synthesis is combined with impaired reuptake.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Young SN. Use of tryptophan in combination with other antidepressant treatments: a review. J Psychiatry Neurosci. 1991;16(5):241-246.Source linkedPMID
• Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001;25(6):871-880.Source linkedPMID

Recommendation

Do not use MDMA while taking duloxetine. Do not increase MDMA doses to overcome duloxetine-related blunting. Seek emergency care for high fever, severe agitation, confusion, clonus, chest pain, fainting, or severe headache after exposure.

Mechanism

MDMA depends on SERT and NET to enter monoamine neurons and drive reverse serotonin and norepinephrine transport. Duloxetine inhibits SERT and NET and can inhibit CYP2D6, altering MDMA pharmacodynamics and potentially its exposure.

• Hysek CM, Simmler LD, Nicola VG, et al. Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study. PLoS One. 2012;7(5):e36476.Source linkedPMID
• Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology (Berl). 2022;239(6):1945-1976.Source linkedPMID
• Makunts T, Jerome L, Abagyan R, de Boer A. Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database. Front Psychiatry. 2021;12:824288.Source linkedPMID

Recommendation

Do not take St. John's Wort with duloxetine under any circumstances. This combination poses dual risks: serotonin syndrome and unpredictable changes in duloxetine levels. Seek alternative mood support options.

Mechanism

Duloxetine blocks SERT and NET. St. John's Wort independently inhibits serotonin reuptake via hyperforin and may inhibit MAO. The combined serotonergic mechanisms create dangerous serotonin excess. Additionally, St. John's Wort may induce CYP1A2, altering duloxetine plasma levels unpredictably.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Avoid nattokinase while using enoxaparin. If the combination has already been used, stop nattokinase and watch for bruising, nosebleeds, black stools, blood in urine, severe headache, or sudden weakness.

Mechanism

Nattokinase directly degrades fibrin and lowers fibrinogen, factor VII, and factor VIII. Enoxaparin enhances antithrombin-mediated factor Xa inhibition, so combined use affects both fibrin formation and fibrin breakdown.

• Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-469.Source linkedPMID
• Hsia CH, et al. Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res. 2009;29(3):190-196.Source linkedPMID

Recommendation

Do not take potassium supplements with eplerenone unless your prescriber specifically orders them and monitors potassium. Avoid potassium-based salt substitutes, and check potassium and kidney function shortly after starting or changing eplerenone.

Mechanism

Eplerenone blocks aldosterone signaling at mineralocorticoid receptors in the distal nephron, reducing potassium secretion. Supplemental potassium adds external potassium load on top of reduced renal excretion.

• Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R; EPHESUS Investigators. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 2008;118(16):1643-1650.Source linkedPMID
• Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348(14):1309-1321.Source linkedPMID
• Ponce SP, Jennings AE, Madias NE, Harrington JT. Drug-induced hyperkalemia. Medicine (Baltimore). 1985;64(6):357-370.Source linkedPMID

Recommendation

Do not combine MDMA with escitalopram. If you stop escitalopram, wait at least 1-2 weeks before any MDMA exposure.

Mechanism

Escitalopram occupies SERT and prevents MDMA from triggering reverse transport of 5-HT. Combined inhibition of serotonin reuptake with MDMA-induced serotonergic activity raises the risk of postsynaptic serotonin toxicity.

• Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013;25(3):193-9.Source linkedPMID
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID

Recommendation

Do not take St. John's Wort with escitalopram. If mood support beyond your SSRI is needed, discuss evidence-based options with your prescriber.

Mechanism

Escitalopram is a highly selective serotonin reuptake inhibitor. St. John's Wort adds serotonin reuptake inhibition via hyperforin and potential MAO inhibition. The dual serotonergic mechanism causes excessive 5-HT receptor stimulation, particularly at 5-HT1A and 5-HT2A receptors.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do not drink alcohol when taking eszopiclone. Skip eszopiclone rather than combining it with alcohol unless your prescriber gives different individualized instructions. Do not drive or perform hazardous tasks if both were used.

Mechanism

Eszopiclone acts at the benzodiazepine site of GABA-A receptors as a nonbenzodiazepine hypnotic. Alcohol adds GABAergic CNS depression and impairs attention, balance, and memory.

• McCrae CS, Lichstein KL. Eszopiclone for late-life insomnia. Clin Interv Aging. 2007;2(3):313-326.Source linkedPMID
• Richter G, Liao VWY, Ahring PK, Chebib M. The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA(A) Receptors Containing gamma1, gamma2, and gamma3 Subunits. Front Neurosci. 2020;14:599812.Source linkedPMID

Recommendation

Do not combine MDMA with fluoxetine. Because fluoxetine and norfluoxetine persist for 4-6 weeks, do not take MDMA for at least 5 weeks after stopping fluoxetine.

Mechanism

Fluoxetine occupies SERT, preventing MDMA from triggering reverse transport of 5-HT into the synapse. Despite blunted subjective effects, residual serotonergic activity plus impaired clearance creates conditions for serotonin syndrome and hyperthermia.

• Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013;25(3):193-9.Source linkedPMID
• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID

Recommendation

Do not take St. John's Wort with fluoxetine. Due to fluoxetine's long half-life, wait at least 5 weeks after stopping fluoxetine before starting St. John's Wort. Seek immediate medical attention for symptoms of serotonin syndrome.

Mechanism

Fluoxetine and its active metabolite norfluoxetine potently inhibit SERT, with a combined half-life of 4-16 days. St. John's Wort's additional serotonin reuptake inhibition (via hyperforin) and potential MAO inhibition creates dangerous serotonergic excess.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Avoid concurrent use. The CYP2D6 interaction compounds the serotonin syndrome risk, making this combination particularly dangerous.

Mechanism

Fluoxetine potently inhibits CYP2D6 and serotonin reuptake. Tramadol also inhibits serotonin reuptake. The combination produces additive serotonergic activity and altered tramadol metabolism.

• Sansone RA, Sansone LA. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont). 2009.Source linkedPMID

Recommendation

Do not take 5-HTP with fluvoxamine. If you have been taking 5-HTP, stop it before starting fluvoxamine and stay off it throughout treatment.

Mechanism

5-HTP is decarboxylated to serotonin throughout the body, including in the CNS. Fluvoxamine blocks SERT, preventing reuptake. The combination produces excess synaptic serotonin and risks 5-HT1A/5-HT2A overstimulation.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID
• Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777-98.Source linkedPMID

Recommendation

Do not take L-tryptophan supplements with fluvoxamine. Food intake of tryptophan is fine; the problem is concentrated supplemental doses.

Mechanism

L-Tryptophan is converted to 5-HTP by tryptophan hydroxylase, then to serotonin. Fluvoxamine blocks SERT, preventing reuptake. Combined, both synthesis and clearance are pushed, raising synaptic 5-HT to toxic levels.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID
• Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777-98.Source linkedPMID

Recommendation

Do not combine St. John's Wort with fluvoxamine. Stop St. John's Wort at least 2 weeks before starting fluvoxamine.

Mechanism

St. John's Wort constituents (hyperforin, hypericin) inhibit synaptic monoamine reuptake including serotonin. Combined with fluvoxamine's SERT blockade, synaptic serotonin can rise to toxic levels.

• Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777-98.Source linkedPMID
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID

Recommendation

Do not drink alcohol while taking hydrocodone. If alcohol was used recently, skip non-urgent opioid dosing and contact your prescriber or pharmacist for individualized guidance. Seek emergency help for extreme sleepiness, slow breathing, blue lips, or inability to wake.

Mechanism

Hydrocodone is a mu-opioid receptor agonist that suppresses brainstem ventilatory drive and reduces arousal responses to rising carbon dioxide. Alcohol adds central nervous system depression through GABAergic and other inhibitory pathways, reducing alertness and airway protective reflexes while opioid respiratory drive is already impaired.

• Jones CM, Paulozzi LJ, Mack KA; Centers for Disease Control and Prevention. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths - United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(40):881-885.Source linkedPMID
• Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A. Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012;18(37):5994-6004.Source linkedPMID

Recommendation

Avoid concurrent prescribing. If no alternative exists, use lowest effective doses for the shortest duration. Monitor closely for respiratory depression.

Mechanism

Synergistic CNS and respiratory depression through combined mu-opioid receptor agonism and GABA-A receptor potentiation.

• Sun EC et al. Association between concurrent use of prescription opioids and benzodiazepines and overdose. BMJ. 2017.Source linkedPMID

Recommendation

Avoid combining ginkgo supplements with repeated ibuprofen dosing. If you have used both and develop severe headache, neurologic symptoms, black stools, vomiting blood, or unusual bruising, seek urgent care.

Mechanism

Ginkgo constituents can inhibit platelet-activating factor signaling and reduce platelet aggregation. Ibuprofen reversibly inhibits platelet COX-1 and also weakens gastric mucosal protection, creating additive bleeding risk.

• Meisel C, Johne A, Roots I. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis. 2003;167(2):367.Source linkedPMID
• Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657-661.Source linkedPMID

Recommendation

Do NOT combine 5-HTP with Isocarboxazid. Use only if the prescriber managing Isocarboxazid explicitly directs it and provides washout instructions.

Mechanism

5-HTP bypasses tryptophan hydroxylase to increase serotonin production; MAOIs inhibit serotonin breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do NOT combine L-tryptophan with Isocarboxazid unless specifically directed and monitored by the prescriber managing Isocarboxazid.

Mechanism

Tryptophan is converted to 5-HTP and then serotonin; MAOIs reduce monoamine breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Avoid high-tyramine foods while taking Isocarboxazid and continue the MAOI diet for the prescriber-recommended washout period after stopping.

Mechanism

MAO-A normally metabolizes dietary tyramine. When MAO-A is inhibited, tyramine can provoke excessive norepinephrine release and dangerous blood-pressure elevation.

• McCabe-Sellers BJ et al. Dietary tyramine and other pressor amines in MAOI regimens: a review. J Am Diet Assoc. 1986.Source linkedPMID
• VanDenBerg CM et al. Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors. CNS Drugs. 2022.Source linkedPMID

Recommendation

Do not take any vitamin A supplements, cod liver oil, or multivitamins containing vitamin A while on isotretinoin. This includes beta-carotene at high doses. Check all supplement labels for vitamin A content.

Mechanism

Isotretinoin is itself a retinoid that activates retinoid receptors (RAR/RXR). Additional vitamin A provides more retinoid activity, causing toxic accumulation. Hypervitaminosis A leads to hepatic stellate cell activation (liver fibrosis), increased intracranial pressure, and severe mucocutaneous toxicity.

• Rothman KJ et al. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333(21):1369-1373.Source linkedPMID

Recommendation

Do not combine. If both have been taken together and breathing is slow or shallow, consciousness is impaired, or vomiting occurs, seek emergency medical care immediately.

Mechanism

Both agents depress the central nervous system: alcohol potentiates GABA-A inhibitory tone while ketamine adds NMDA receptor antagonism and dissociation, so the combination compounds sedation and blunts protective airway reflexes.

• Kobayashi NHC et al. Ketamine plus Alcohol: What We Know and What We Can Expect about This. Int J Mol Sci. 2022;23(14).Source linkedPMID

Recommendation

Do NOT combine L-tryptophan with SSRIs, SNRIs, MAOIs, or other serotonergic medications unless specifically directed by the prescriber managing the medication.

Mechanism

L-Tryptophan is converted to 5-HTP and then serotonin. SSRIs/SNRIs reduce serotonin reuptake and MAOIs reduce monoamine breakdown, creating additive serotonergic excess.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do NOT combine without medical supervision.

Mechanism

L-Tryptophan is converted to serotonin via tryptophan hydroxylase; St. John's Wort blocks reuptake via hyperforin. Combined effect accumulates excess synaptic serotonin.

• Borrelli F et al. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J. 2009;11(4):710-27.Source linkedPMID
• Fernstrom JD. A Perspective on the Safety of Supplemental Tryptophan Based on Its Metabolic Fates. J Nutr. 2016;146(12):2601S-2608S.Source linkedPMID
• Boyer EW et al. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID

Recommendation

Do not use cocaine while taking lisdexamfetamine. Do not raise or repeat either substance to overcome a blunted effect. Seek emergency care for chest pain, severe headache, fainting, shortness of breath, confusion, severe agitation, or an irregular heartbeat.

Mechanism

Lisdexamfetamine is a prodrug that produces systemic dextroamphetamine exposure. Cocaine blocks monoamine reuptake and has direct cardiac ion-channel effects, while dextroamphetamine increases catecholamine release; together they can amplify adrenergic load.

• Mooney ME, Herin DV, Specker S, Babb D, Levin FR, Grabowski J. Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend. 2015;153:94-103.Source linkedPMID
• Dolder PC, Strajhar P, Vizeli P, Hammann F, Odermatt A, Liechti ME. Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects. Front Pharmacol. 2017;8:617.Source linkedPMID
• Kim ST, Park T. Acute and Chronic Effects of Cocaine on Cardiovascular Health. Int J Mol Sci. 2019;20(3):584.Source linkedPMID

Recommendation

Do not use MDMA while taking lisdexamfetamine. Skipping or delaying a single dose does not reliably remove risk because stimulant effects may persist for much of the day. Seek emergency care for high fever, confusion, severe agitation, chest pain, fainting, seizure, or an irregular heartbeat.

Mechanism

Lisdexamfetamine is converted in blood to dextroamphetamine, which increases catecholamine release. MDMA releases serotonin, norepinephrine, and dopamine through monoamine transporters, producing overlapping cardiovascular stimulation and thermoregulatory stress.

• Dolder PC, Strajhar P, Vizeli P, Hammann F, Odermatt A, Liechti ME. Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects. Front Pharmacol. 2017;8:617.Source linkedPMID
• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID
• Steinkellner T, Freissmuth M, Sitte HH, Montgomery T. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine. Biol Chem. 2011;392(1-2):103-115.Source linkedPMID

Recommendation

Avoid alcohol while taking lorazepam. If alcohol was used, do not take extra lorazepam for anxiety or sleep without medical guidance. Seek urgent care for severe sedation, slow breathing, or inability to stay awake.

Mechanism

Lorazepam potentiates GABA-A receptor signaling. Alcohol adds GABAergic inhibition and reduces excitatory glutamatergic tone, causing additive CNS depression independent of hepatic metabolism.

• Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health. 1999;23(1):40-54.Source linkedPMID
• Drummer OH. Benzodiazepines - Effects on Human Performance and Behavior. Forensic Sci Rev. 2002;14(1-2):1-14.Source linkedPMID

Recommendation

Avoid grapefruit and grapefruit juice while taking lovastatin unless your prescriber specifically says otherwise.

Mechanism

Furanocoumarins in grapefruit inhibit intestinal CYP3A4, reducing first-pass metabolism of lovastatin.

• Bailey DG et al. Grapefruit juice-drug interactions. Br J Clin Pharmacol. 1998.Source linkedPMID

Recommendation

Do NOT combine 5-HTP with MAOIs. Use only if the prescriber managing the MAOI explicitly directs it and provides washout instructions.

Mechanism

5-HTP bypasses tryptophan hydroxylase to increase serotonin production; MAOIs inhibit serotonin breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do NOT combine L-tryptophan with MAOIs unless specifically directed and monitored by the prescriber managing the MAOI.

Mechanism

Tryptophan is converted to 5-HTP and then serotonin; MAOIs reduce monoamine breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Avoid high-tyramine foods while taking irreversible MAOIs and continue the MAOI diet for the prescriber-recommended washout period after stopping.

Mechanism

MAO-A normally metabolizes dietary tyramine. When MAO-A is inhibited, tyramine can provoke excessive norepinephrine release and dangerous blood-pressure elevation.

• McCabe-Sellers BJ et al. Dietary tyramine and other pressor amines in MAOI regimens: a review. J Am Diet Assoc. 1986.Source linkedPMID
• VanDenBerg CM et al. Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors. CNS Drugs. 2022.Source linkedPMID

Recommendation

Do not combine. If symptoms such as high fever, confusion, severe muscle stiffness, or rapid heartbeat develop, seek emergency medical care immediately.

Mechanism

MDMA causes massive synaptic serotonin release while 5-HTP supplies extra precursor that boosts serotonin synthesis, and the combined surge can overwhelm serotonergic regulation and trigger serotonin syndrome.

• Boyer EW et al. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID
• Liechti ME. Effects of MDMA on body temperature in humans. Temperature (Austin). 2014;1(3):192-200.Source linkedPMID

Recommendation

Do not combine. Watch for high fever, agitation, tremor, or muscle rigidity and seek emergency medical care if they appear.

Mechanism

L-Tryptophan is the upstream precursor for serotonin synthesis, and adding it while MDMA drives large serotonin release can push serotonergic signaling into a dangerous excess.

• Boyer EW et al. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID
• Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95(4):434-41.Source linkedPMID

Recommendation

Do not use cocaine while taking methylphenidate. Do not take extra methylphenidate to counter cocaine withdrawal or fatigue. Seek emergency care for chest pain, severe headache, fainting, severe anxiety or agitation, shortness of breath, or a racing or irregular heartbeat.

Mechanism

Methylphenidate blocks DAT and NET, increasing dopamine and norepinephrine signaling. Cocaine also blocks DAT, NET, and SERT and can impair cardiac conduction through sodium-channel blockade, creating additive stimulant and cardiovascular toxicity potential.

• Winhusen T, Somoza E, Singal BM, et al. Methylphenidate and cocaine: a placebo-controlled drug interaction study. Pharmacol Biochem Behav. 2006;85(1):29-38.Source linkedPMID
• Volkow ND, Wang GJ, Fowler JS, et al. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl). 2003;166(3):264-270.Source linkedPMID
• Kim ST, Park T. Acute and Chronic Effects of Cocaine on Cardiovascular Health. Int J Mol Sci. 2019;20(3):584.Source linkedPMID

Recommendation

Do not use MDMA while taking methylphenidate. Do not take extra MDMA if the effect feels blunted or different. Seek emergency care for high fever, confusion, severe agitation, chest pain, fainting, seizure, or a racing or irregular heartbeat.

Mechanism

Methylphenidate blocks dopamine and norepinephrine transporters, while MDMA enters monoamine neurons through transporters and promotes serotonin, norepinephrine, and dopamine release. The combination increases autonomic and endocrine stress without reliably increasing desired subjective effects.

• Hysek CM, Simmler LD, Schillinger N, et al. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. Int J Neuropsychopharmacol. 2014;17(3):371-381.Source linkedPMID
• Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology (Berl). 2022;239(6):1945-1976.Source linkedPMID
• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID

Recommendation

Do not drink alcohol while taking metronidazole. Wait at least 3 days (72 hours) after your last dose before consuming alcohol, including alcohol in mouthwashes, cough syrups, and food preparations.

Mechanism

Metronidazole inhibits hepatic and intestinal acetaldehyde dehydrogenase (ALDH), causing acetaldehyde accumulation when ethanol is consumed. Some animal data also suggest intracolonic acetaldehyde accumulation via altered gut flora.

• Williams CS, Woodcock KR. Do ethanol and metronidazole interact to produce a disulfiram-like reaction? Ann Pharmacother. 2000;34(2):255-257.Source linkedPMID
• Tillonen J, Väkeväinen S, Salaspuro V, et al. Metronidazole increases intracolonic but not peripheral blood acetaldehyde in chronic ethanol-treated rats. Alcohol Clin Exp Res. 2000;24(4):570-5.Source linkedPMID
• Feldman R, Jaszczenski R. Can Metronidazole Cause a Disulfiram-Like Reaction? A Case-Control Study Propensity Matched by Age, Sex, and Ethanol Concentration. WMJ. 2023;122(3):171-177.Source linkedPMID

Recommendation

Do not drink alcohol while taking morphine. If you accidentally combine them, avoid taking more morphine or other sedatives and make sure someone can monitor you. Seek emergency care for slow breathing, confusion, blue lips, or inability to stay awake.

Mechanism

Morphine depresses brainstem respiratory rhythm and blunts carbon dioxide responsiveness through mu-opioid receptor signaling. Alcohol independently depresses central nervous system activity and arousal, making it harder to compensate for opioid-suppressed breathing.

• Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A. Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012;18(37):5994-6004.Source linkedPMID
• Jones CM, Paulozzi LJ, Mack KA; Centers for Disease Control and Prevention. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths - United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(40):881-885.Source linkedPMID

Recommendation

Avoid combination. If absolutely necessary in a monitored setting, use lowest possible doses with continuous pulse oximetry monitoring.

Mechanism

Morphine activates mu-opioid receptors depressing respiratory drive. Diazepam (and active metabolites with very long half-lives) enhances GABA-mediated CNS depression. Combined effect on respiratory centers is synergistic.

• Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017;356:j760.Source linkedPMID
• Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert ASB. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698.Source linkedPMID

Recommendation

Do not drink alcohol while taking oxycodone. Avoid driving, sleeping alone after accidental co-use, or taking any extra sedatives. Call emergency services if breathing becomes slow, shallow, noisy, or difficult to wake from.

Mechanism

Oxycodone activates mu-opioid receptors in respiratory control circuits, lowering the ventilatory response to carbon dioxide. Alcohol adds central nervous system depression and reduces arousal, creating additive or synergistic impairment of breathing and airway protection.

• van der Schrier R, Roozekrans M, Olofsen E, Aarts L, van Velzen M, de Jong M, et al. Influence of Ethanol on Oxycodone-induced Respiratory Depression: A Dose-escalating Study in Young and Elderly Individuals. Anesthesiology. 2017;126(3):534-542.Source linkedPMID
• Jones CM, Paulozzi LJ, Mack KA; Centers for Disease Control and Prevention. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths - United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(40):881-885.Source linkedPMID

Recommendation

Avoid concurrent prescribing whenever possible. If combined, use the lowest doses for the shortest duration. Inform patients about the risk of respiratory depression. Ensure naloxone is available.

Mechanism

Opioids depress brainstem respiratory centers via mu-receptor activation. Benzodiazepines enhance GABA-A-mediated inhibition, also depressing respiration. Combined CNS depression is synergistic, not merely additive.

• Sun EC et al. Association between concurrent use of prescription opioids and benzodiazepines and overdose. BMJ. 2017.Source linkedPMID

Recommendation

Do NOT take 5-HTP with paroxetine.

Mechanism

Paroxetine has the highest SERT binding affinity of all SSRIs. Adding 5-HTP (serotonin precursor) dramatically increases synaptic serotonin, risking serotonin syndrome.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Truyens M, Lobatón T, Ferrante M et al.. Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial. Gastroenterology. 2022.Source linkedPMID
• Sutanto CN, Xia X, Heng CW et al.. The impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: A randomized controlled trial. Clinical Nutrition. 2024.Source linkedPMID

Recommendation

Do not take L-tryptophan supplements with paroxetine. Dietary protein-bound tryptophan is fine; concentrated supplemental doses are the issue.

Mechanism

L-Tryptophan is converted to 5-HTP then serotonin. Paroxetine blocks the serotonin transporter; both inputs raise synaptic serotonin to potentially toxic concentrations.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID
• Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777-98.Source linkedPMID

Recommendation

Do not combine MDMA with paroxetine. If paroxetine is stopped, wait at least 1-2 weeks before any MDMA use.

Mechanism

Paroxetine blocks SERT (preventing MDMA-induced serotonin release) and strongly inhibits CYP2D6 (impairing MDMA clearance). Net result: higher MDMA levels with disrupted serotonergic clearance.

• Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013;25(3):193-9.Source linkedPMID
• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID

Recommendation

Do NOT combine. Allow at least 2 weeks washout after stopping paroxetine before starting SJW.

Mechanism

Both paroxetine and hyperforin inhibit SERT. Combined SERT blockade causes excessive synaptic serotonin accumulation.

• Lantz MS et al. St. John's wort and antidepressant drug interactions. J Geriatr Psychiatry Neurol. 1999;12(1):7-10.Source linkedPMID

Recommendation

Do NOT combine 5-HTP with Phenelzine. Use only if the prescriber managing Phenelzine explicitly directs it and provides washout instructions.

Mechanism

5-HTP bypasses tryptophan hydroxylase to increase serotonin production; MAOIs inhibit serotonin breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do NOT combine L-tryptophan with Phenelzine unless specifically directed and monitored by the prescriber managing Phenelzine.

Mechanism

Tryptophan is converted to 5-HTP and then serotonin; MAOIs reduce monoamine breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Avoid high-tyramine foods while taking Phenelzine and continue the MAOI diet for the prescriber-recommended washout period after stopping.

Mechanism

MAO-A normally metabolizes dietary tyramine. When MAO-A is inhibited, tyramine can provoke excessive norepinephrine release and dangerous blood-pressure elevation.

• McCabe-Sellers BJ et al. Dietary tyramine and other pressor amines in MAOI regimens: a review. J Am Diet Assoc. 1986.Source linkedPMID
• VanDenBerg CM et al. Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors. CNS Drugs. 2022.Source linkedPMID

Recommendation

Avoid nattokinase while taking prasugrel unless your cardiologist specifically approves it. Do not use nattokinase as a substitute for prescribed antiplatelet therapy. Seek urgent care for severe headache, weakness on one side, black stools, vomiting blood, or bleeding that does not stop.

Mechanism

Prasugrel irreversibly inhibits platelet P2Y12 receptors, reducing ADP-mediated platelet aggregation. Nattokinase cleaves fibrin and can lower fibrinogen, factor VII, and factor VIII, creating additive impairment of clot formation and clot stability.

• Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-469.Source linkedPMID
• Hsia CH, Shen MC, Lin JS, Wen YK, Hwang KL, Cham TM, et al. Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res. 2009;29(3):190-196.Source linkedPMID
• Kurosawa Y, Nirengi S, Homma T, Esaki K, Ohta M, Clark JF, et al. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Sci Rep. 2015;5:11601.Source linkedPMID

Recommendation

Do not use pseudoephedrine if you have used cocaine or may use cocaine soon. Seek urgent care for chest pain, severe headache, fainting, severe agitation, or a very fast or irregular heartbeat. Use non-stimulant congestion treatments instead.

Mechanism

Pseudoephedrine indirectly increases synaptic norepinephrine and activates alpha and beta adrenergic pathways. Cocaine blocks norepinephrine, dopamine, and serotonin reuptake and also causes vasoconstriction and sodium-channel effects, making the cardiovascular load additive and potentially unstable.

• Salerno SM, Jackson JL, Berbano EP. Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. Arch Intern Med. 2005;165(15):1686-1694.Source linkedPMID
• Kim ST, Park T. Acute and Chronic Effects of Cocaine on Cardiovascular Health. Int J Mol Sci. 2019;20(3):584.Source linkedPMID
• Schindler CW. Cocaine and cardiovascular toxicity. Addict Biol. 1996;1(1):31-47.Source linkedPMID

Recommendation

Do not use pseudoephedrine if you have used MDMA or may use MDMA soon. Seek urgent help for chest pain, severe headache, overheating, fainting, confusion, or a racing or irregular heartbeat. Use non-stimulant nasal congestion options instead.

Mechanism

Pseudoephedrine increases adrenergic signaling through norepinephrine release and alpha/beta receptor stimulation. MDMA increases monoamine release, including norepinephrine, and produces sympathomimetic cardiovascular stimulation and thermogenic stress; together they can amplify rate-pressure product and heat strain.

• Salerno SM, Jackson JL, Berbano EP. Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. Arch Intern Med. 2005;165(15):1686-1694.Source linkedPMID
• Hysek C, Schmid Y, Rickli A, et al. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. Br J Pharmacol. 2012;166(8):2277-2288.Source linkedPMID
• Kirkpatrick MG, Gunderson EW, Perez AY, Haney M, Foltin RW, Hart CL. A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl). 2012;219(1):109-122.Source linkedPMID

Recommendation

Do not combine. If you take any lithium-containing product, do not use psilocybin and seek medical advice.

Mechanism

Lithium appears to lower seizure threshold and alter serotonergic and intracellular signaling in a way that markedly increases the risk of seizures and severe reactions when combined with serotonergic psychedelics.

• Nayak SM et al. Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry. 2021;54(5):240-245.Source linkedPMID

Recommendation

Do NOT take St. John's Wort with quetiapine. This combination is contraindicated due to the risk of complete loss of antipsychotic efficacy. If you are currently taking both, contact your prescriber immediately. Do not abruptly stop St. John's Wort as quetiapine levels will rise over 7-14 days.

Mechanism

Hyperforin in St. John's Wort potently activates PXR, inducing CYP3A4 transcription and increasing quetiapine hepatic metabolism. Quetiapine is extensively metabolized by CYP3A4, and enzyme induction can reduce plasma levels below the minimum effective concentration. The FDA label acknowledges this by recommending up to 5-fold dose increases with strong CYP3A4 inducers.

• Grimm SW, Richtand NM, Winter HR, Stams KR, Reele SB. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. Br J Clin Pharmacol. 2006;61(1):58-69.Source linkedPMID
• Nicolussi S et al. Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol. 2020;177(6):1212-1226.Source linkedPMID

Recommendation

Do not combine nattokinase with rivaroxaban. If you have been taking both, stop the nattokinase and contact your prescriber, especially if you notice any unusual bruising or bleeding.

Mechanism

Nattokinase is a serine protease that directly cleaves fibrin and activates plasminogen, plus reducing plasma fibrinogen, factor VII, and factor VIII. These mechanisms compound rivaroxaban's factor Xa inhibition.

• Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-9.Source linkedPMID
• Elahi MM, Choi CH, Konda S, Shake JG. Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis. Proc (Bayl Univ Med Cent). 2015;28(1):81-2.Source linkedPMID

Recommendation

Do not combine MDMA with rizatriptan. If MDMA was used, avoid taking rizatriptan and seek medical advice for severe headache, chest pain, high fever, confusion, muscle rigidity, or repeated vomiting. Treat fever, agitation, clonus, or confusion after overlap as an emergency.

Mechanism

MDMA reverses serotonin transporter function and drives marked serotonin release. Rizatriptan activates 5-HT1B/1D receptors; combined serotonergic stress can worsen receptor overstimulation and make early toxicity harder to recognize.

• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Evans RW. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports. MedGenMed. 2007;9(3):48.Source linkedPMID

Recommendation

Do NOT combine without close psychiatric supervision. Risk of mania especially high in patients with bipolar disorder.

Mechanism

SAMe donates methyl groups in serotonin synthesis. SSRIs block reuptake. Combined effect risks serotonergic excess.

• SAMe-induced mania case reportSource linkedPMID

Recommendation

Do NOT combine. Schisandra dramatically increases immunosuppressant levels.

Mechanism

Schisandra lignans potently inhibit CYP3A4 and P-glycoprotein short-term, dramatically increasing tacrolimus/cyclosporine exposure.

• Schisandra tacrolimus AUC increase 164%Source linkedPMID

Recommendation

Do NOT combine 5-HTP with Selegiline. Use only if the prescriber managing Selegiline explicitly directs it and provides washout instructions.

Mechanism

5-HTP bypasses tryptophan hydroxylase to increase serotonin production; MAOIs inhibit serotonin breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do NOT combine L-tryptophan with Selegiline unless specifically directed and monitored by the prescriber managing Selegiline.

Mechanism

Tryptophan is converted to 5-HTP and then serotonin; MAOIs reduce monoamine breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Follow the prescriber-specific tyramine restrictions for your selegiline formulation and dose. Avoid high-tyramine foods whenever MAOI dietary restrictions apply.

Mechanism

MAO-A normally metabolizes dietary tyramine. When MAO-A is substantially inhibited, tyramine can provoke excessive norepinephrine release and dangerous blood-pressure elevation; selegiline selectivity varies by dose and formulation.

• McCabe-Sellers BJ et al. Dietary tyramine and other pressor amines in MAOI regimens: a review. J Am Diet Assoc. 1986.Source linkedPMID
• VanDenBerg CM et al. Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors. CNS Drugs. 2022.Source linkedPMID

Recommendation

Do not combine MDMA with sertraline. If you are prescribed sertraline, treat MDMA as off-limits. Even after stopping sertraline, wait at least 1-2 weeks before any MDMA exposure.

Mechanism

MDMA produces serotonergic effects by entering the presynaptic neuron via SERT and triggering reverse transport of vesicular 5-HT into the synapse. SSRIs occupy and inhibit SERT, blunting MDMA's intended release while still permitting massive cumulative serotonergic load and hyperthermia.

• Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013;25(3):193-9.Source linkedPMID
• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID

Recommendation

Do not take St. John's Wort with sertraline or any SSRI. This is a well-documented dangerous interaction with risk of serotonin syndrome (symptoms include agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle twitching, and hyperthermia).

Mechanism

Sertraline blocks the serotonin transporter (SERT), increasing synaptic serotonin. St. John's Wort also inhibits serotonin reuptake (via hyperforin) and may inhibit monoamine oxidase. The combined serotonergic effects can cause excessive serotonin accumulation at postsynaptic 5-HT receptors, triggering serotonin syndrome.

• Lantz MS, Buchalter E, Giambanco V. St. John's wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol. 1999;12(1):7-10.Source linkedPMID
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Avoid concurrent use. If both are necessary, use the lowest effective doses with close monitoring for serotonin syndrome symptoms. Seek immediate medical attention for fever, agitation, or muscle rigidity.

Mechanism

Tramadol inhibits serotonin reuptake in addition to its opioid activity. Combined with SSRI serotonin reuptake inhibition, excessive serotonergic activity can precipitate serotonin syndrome.

• Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005.Source linkedPMID

Recommendation

Contraindicated. Suspend simvastatin during clarithromycin treatment. If statin therapy is needed, use pravastatin or rosuvastatin (not CYP3A4 metabolized).

Mechanism

Simvastatin is extensively metabolized by CYP3A4. Clarithromycin potently inhibits CYP3A4, causing massive accumulation of simvastatin and its active metabolite, leading to myotoxicity.

• Jacobson TA. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. Am J Cardiol. 2004.Source linkedPMID

Recommendation

Avoid grapefruit and grapefruit juice while taking simvastatin unless your prescriber specifically says otherwise.

Mechanism

Furanocoumarins in grapefruit inhibit intestinal CYP3A4, reducing first-pass metabolism of simvastatin.

• Bailey DG et al. Grapefruit juice-drug interactions. Br J Clin Pharmacol. 1998.Source linkedPMID

Recommendation

Do NOT take potassium supplements with spironolactone unless specifically prescribed with close monitoring. Avoid potassium-containing salt substitutes. This combination can be lethal.

Mechanism

Spironolactone blocks mineralocorticoid receptors in the collecting duct, preventing aldosterone-driven potassium excretion via ROMK and BK channels. Exogenous potassium on top of retained potassium = dangerous hyperkalemia.

• Palmer BF. Managing hyperkalemia caused by RAAS inhibitors. N Engl J Med. 2004;351(6):585-592.Source linkedPMID
• Filippini T, Naska A, Kasdagli MI et al.. Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2020.Source linkedPMID
• Behers BJ, Behers BM, Stephenson-Moe CA et al.. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length. Nutrients. 2024.Source linkedPMID
• D'Elia L, Cappuccio FP, Masulli M et al.. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients. 2023.Source linkedPMID

Recommendation

Do not combine MDMA with sumatriptan. If MDMA was used, avoid taking sumatriptan and seek medical advice for severe headache, chest pain, high fever, confusion, muscle rigidity, or repeated vomiting. Treat fever, agitation, clonus, or confusion after overlap as an emergency.

Mechanism

MDMA enters monoamine neurons and reverses serotonin transporter function, producing marked synaptic serotonin release and hyperthermia risk. Sumatriptan activates 5-HT1B/1D receptors; combined serotonergic stress can worsen receptor overstimulation and obscure early toxicity symptoms.

• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Evans RW. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports. MedGenMed. 2007;9(3):48.Source linkedPMID

Recommendation

Avoid nattokinase while taking ticagrelor unless your cardiologist has explicitly approved it. Do not manage this by separating doses because both effects persist beyond the dosing window. Get urgent help for severe headache, one-sided weakness, black stools, vomiting blood, or uncontrolled bleeding.

Mechanism

Ticagrelor reversibly inhibits platelet P2Y12 receptors and reduces ADP-driven platelet activation. Nattokinase promotes fibrinolysis and can lower fibrinogen, factor VII, and factor VIII, so the combination can impair both platelet plug formation and fibrin clot stability.

• Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-469.Source linkedPMID
• Hsia CH, Shen MC, Lin JS, Wen YK, Hwang KL, Cham TM, et al. Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res. 2009;29(3):190-196.Source linkedPMID
• Kurosawa Y, Nirengi S, Homma T, Esaki K, Ohta M, Clark JF, et al. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Sci Rep. 2015;5:11601.Source linkedPMID

Recommendation

Do not drink alcohol while taking tramadol. Avoid extra doses if alcohol was used, and do not combine tramadol with sleep aids or other sedatives. Seek emergency care for slow breathing, fainting, seizure, or inability to wake.

Mechanism

Tramadol produces mu-opioid agonism and inhibits serotonin and norepinephrine reuptake. Alcohol adds central nervous system depression and impaired arousal, increasing sedation and respiratory risk; both substances can also contribute to impaired seizure control in susceptible people.

• Jones CM, Paulozzi LJ, Mack KA; Centers for Disease Control and Prevention. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths - United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(40):881-885.Source linkedPMID
• Beakley BD, Kaye AM, Kaye AD. Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review. Pain Physician. 2015;18(4):395-400.Source linkedPMID

Recommendation

Do not combine MDMA with tramadol. Avoid tramadol after MDMA exposure until you have medical guidance, especially if you have overheating, agitation, tremor, diarrhea, confusion, or muscle rigidity. Seek emergency care for fever, seizure, severe agitation, or altered consciousness.

Mechanism

MDMA is a monoamine releaser and uptake inhibitor with strong serotonergic effects. Tramadol inhibits serotonin reuptake and can provoke seizures; overlapping serotonergic and pro-convulsant effects increase toxicity risk.

• Beakley BD, Kaye AM, Kaye AD. Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review. Pain Physician. 2015;18(4):395-400.Source linkedPMID
• Makunts T, Jerome L, Abagyan R, de Boer A. Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database. Front Psychiatry. 2021;12:824288.Source linkedPMID
• Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology. 1995;45(2):219-223.Source linkedPMID

Recommendation

Do not take St. John's Wort with tramadol. This combination poses both serotonin syndrome risk and potential loss of pain control. Seek alternative mood support from your prescriber.

Mechanism

Both tramadol and St. John's Wort inhibit serotonin reuptake, creating additive serotonergic toxicity risk. Additionally, St. John's Wort induces CYP2D6 (which converts tramadol to its active M1 metabolite) and CYP3A4, potentially causing unpredictable changes in tramadol and M1 levels.

• Beakley BD et al. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015;18(4):395-400.Source linkedPMID

Recommendation

Do NOT combine 5-HTP with Tranylcypromine. Use only if the prescriber managing Tranylcypromine explicitly directs it and provides washout instructions.

Mechanism

5-HTP bypasses tryptophan hydroxylase to increase serotonin production; MAOIs inhibit serotonin breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do NOT combine L-tryptophan with Tranylcypromine unless specifically directed and monitored by the prescriber managing Tranylcypromine.

Mechanism

Tryptophan is converted to 5-HTP and then serotonin; MAOIs reduce monoamine breakdown.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Avoid high-tyramine foods while taking Tranylcypromine and continue the MAOI diet for the prescriber-recommended washout period after stopping.

Mechanism

MAO-A normally metabolizes dietary tyramine. When MAO-A is inhibited, tyramine can provoke excessive norepinephrine release and dangerous blood-pressure elevation.

• McCabe-Sellers BJ et al. Dietary tyramine and other pressor amines in MAOI regimens: a review. J Am Diet Assoc. 1986.Source linkedPMID
• VanDenBerg CM et al. Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors. CNS Drugs. 2022.Source linkedPMID

Recommendation

Do NOT take 5-HTP with trazodone. If additional sleep support is needed, discuss non-serotonergic options with your prescriber.

Mechanism

Trazodone blocks SERT and antagonizes 5-HT2A receptors. While the 5-HT2A antagonism might seem protective, SERT blockade combined with 5-HTP-derived serotonin excess still poses serotonin syndrome risk.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Truyens M, Lobatón T, Ferrante M et al.. Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial. Gastroenterology. 2022.Source linkedPMID
• Sutanto CN, Xia X, Heng CW et al.. The impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: A randomized controlled trial. Clinical Nutrition. 2024.Source linkedPMID

Recommendation

Do not take L-tryptophan supplements with trazodone. Food sources of tryptophan are fine.

Mechanism

L-Tryptophan is decarboxylated to serotonin. Trazodone blocks SERT and its mCPP metabolite agonizes 5-HT receptors. Combined, supply and signal both rise, risking 5-HT receptor overstimulation.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID
• Rotzinger S, Fang J, Baker GB. Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources. Drug Metab Dispos. 1998;26(6):572-5.Source linkedPMID

Recommendation

Do not take vitamin A supplements, cod liver oil, or high-retinol multivitamins during oral tretinoin therapy unless your oncology team explicitly prescribes them. Bring all supplements to medication reconciliation. Report severe headache, vision changes, abdominal pain, jaundice, or pregnancy exposure immediately.

Mechanism

Tretinoin is all-trans retinoic acid and directly activates retinoic acid receptors. Preformed vitamin A can be metabolized into active retinoids, increasing the total retinoid burden and the risk of hypervitaminosis A-like toxicity.

• Kamm JJ. Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids. J Am Acad Dermatol. 1982;6(4 Pt 2 Suppl):652-659.Source linkedPMID
• Carazo A, Macakova K, Matousova K, et al. Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity. Nutrients. 2021;13(5):1703.Source linkedPMID

Recommendation

Avoid routine potassium supplementation during trimethoprim-sulfamethoxazole therapy unless directed by a clinician. If supplementation is necessary, monitor serum potassium closely, particularly in older adults or patients with kidney disease.

Mechanism

Trimethoprim blocks the amiloride-sensitive epithelial sodium channel (ENaC) in the collecting duct, reducing sodium reabsorption and decreasing the electrochemical gradient that drives potassium secretion. The net effect is potassium retention.

• Chan WY, Clark AB, Wilson AM, Loke YK, TIPAC investigators. The effect of co-trimoxazole on serum potassium concentration: safety evaluation of a randomized controlled trial. Br J Clin Pharmacol. 2017;83(8):1808-1814.Source linkedPMID
• Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone. CMAJ. 2015;187(4):E138-E143.Source linkedPMID
• Crellin E, Mansfield KE, Leyrat C, et al. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. BMJ. 2018;360:k341.Source linkedPMID

Recommendation

Do not combine L-tryptophan supplements with venlafaxine. If you are using L-tryptophan for sleep or mood, stop it and ask your prescriber for a safer alternative. Watch for tremor, sweating, agitation, diarrhea, fever, or muscle jerking if exposure occurred.

Mechanism

L-Tryptophan is converted by tryptophan hydroxylase to 5-HTP and then to serotonin. Venlafaxine inhibits SERT, especially at lower doses, reducing serotonin clearance from the synapse while precursor supply is increased.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Young SN. Use of tryptophan in combination with other antidepressant treatments: a review. J Psychiatry Neurosci. 1991;16(5):241-246.Source linkedPMID
• Sansone RA, Sansone LA. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. Innov Clin Neurosci. 2014;11(3-4):37-42.Source linkedPMID

Recommendation

Do not use MDMA while taking venlafaxine. Do not try to overcome a blunted MDMA effect by taking more; that raises toxicity risk. If exposure occurs and you develop high fever, agitation, confusion, clonus, chest pain, or severe headache, seek emergency care.

Mechanism

MDMA enters neurons through SERT, NET, and DAT and promotes reverse transport of monoamines, especially serotonin. Venlafaxine inhibits SERT and NET, creating transporter competition plus additive serotonergic and adrenergic stress.

• Makunts T, Jerome L, Abagyan R, de Boer A. Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database. Front Psychiatry. 2021;12:824288.Source linkedPMID
• Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology (Berl). 2022;239(6):1945-1976.Source linkedPMID
• Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55(3):463-508.Source linkedPMID

Recommendation

Do not take St. John's Wort with venlafaxine. This is a well-documented dangerous combination. If you are currently using both, contact your prescriber immediately.

Mechanism

Venlafaxine blocks SERT and NET. St. John's Wort adds serotonin reuptake inhibition (hyperforin) and potential MAO inhibition. CYP2D6 and CYP3A4 induction by St. John's Wort may also alter venlafaxine metabolism, creating unpredictable drug levels alongside pharmacodynamic serotonergic toxicity.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do not start, stop, or sharply change THC-dominant cannabis use without telling your anticoagulation clinic. Ask for an INR check within 3-7 days after any change and again after the pattern stabilizes. Seek urgent care for black stools, vomiting blood, severe headache, weakness, or bleeding that does not stop.

Mechanism

Delta-9-THC can inhibit CYP2C9-mediated warfarin metabolism, increasing S-warfarin exposure and INR. Cannabinoid products may also vary widely in THC/CBD content, making the pharmacokinetic effect hard to predict.

• Damkier P, Lassen D, Christensen MMH, Madsen KG, Hellfritzsch M, Pottegård A. Interaction between warfarin and cannabis. Basic Clin Pharmacol Toxicol. 2019;124(1):28-31.Source linkedPMID
• Greger J, Bates V, Mechtler L, Gengo F. A Review of Cannabis and Interactions With Anticoagulant and Antiplatelet Agents. J Clin Pharmacol. 2020;60(4):432-438.Source linkedPMID
• Smythe MA, Wu W, Garwood CL. Anticoagulant drug-drug interactions with cannabinoids: A systematic review. Pharmacotherapy. 2023;43(12):1327-1338.Source linkedPMID

Recommendation

Do not combine nattokinase with warfarin. Never substitute nattokinase for prescribed warfarin, especially after mechanical valve replacement or for atrial fibrillation. If you have started nattokinase, stop it and contact your anticoagulation clinic.

Mechanism

Nattokinase is a serine protease from fermented soybeans that cleaves fibrin directly and indirectly activates the fibrinolytic system by converting plasminogen to plasmin. It also reduces fibrinogen, factor VII, and factor VIII levels. These effects add to warfarin's reduction of clotting factor synthesis.

• Chang YY, Liu JS, Lai SL, Wu HS, Lan MY. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern Med. 2008;47(5):467-9.Source linkedPMID
• Elahi MM, Choi CH, Konda S, Shake JG. Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis. Proc (Bayl Univ Med Cent). 2015;28(1):81-2.Source linkedPMID

Recommendation

Do not take St. John's Wort with warfarin. This is a well-established dangerous interaction. If you are currently taking both, consult your prescriber immediately, do not abruptly stop St. John's Wort as INR may rebound sharply.

Mechanism

Hyperforin in St. John's Wort is a potent activator of the pregnane X receptor (PXR), which upregulates CYP3A4, CYP2C9, and P-glycoprotein expression. Both S-warfarin (CYP2C9 substrate) and R-warfarin (CYP3A4 substrate) are metabolized faster, reducing anticoagulant effect by up to 50%.

• Jiang X et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2004;57(5):592-599.Source linkedPMID
• Yue QY et al. Safety of St John's wort (Hypericum perforatum). Lancet. 2000;355(9203):576-577.Source linkedPMID
• Wang M, Zeraatkar D, Obeda M, Lee M et al.. Drug-drug interactions with warfarin: A systematic review and meta-analysis. British Journal of Clinical Pharmacology. 2021.Source linkedPMID

Recommendation

Do not drink alcohol on nights you take zolpidem. Do not take zolpidem after drinking, even if you feel awake. Seek help if sleepwalking, sleep-driving, severe confusion, or unusual behavior occurs.

Mechanism

Zolpidem is a GABA-A receptor positive modulator with relative alpha-1 selectivity. Alcohol adds broad CNS depression through GABA-A potentiation and NMDA inhibition, worsening vigilance, memory, balance, and reaction time.

• Wilkinson CJ. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function. J Clin Psychiatry. 1995;56(7):309-318.Source linkedPMID
• Poceta JS. Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series. J Clin Sleep Med. 2011;7(6):632-638.Source linkedPMID

Recommendation

Do not treat alcohol use as safe. If alcohol is consumed regularly, arrange thiamine repletion under medical supervision, and seek medical advice for any neurological symptoms.

Mechanism

Alcohol reduces active transport of thiamine across the intestinal mucosa and inhibits hepatic conversion of thiamine to its active coenzyme thiamine pyrophosphate, while increasing urinary thiamine loss.

• Thomson AD et al. The natural history and pathophysiology of Wernicke's Encephalopathy and Korsakoff's Psychosis. Alcohol Alcohol. 2006;41(2):151-8.Source linkedPMID
• Martin PR et al. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health. 2003;27(2):134-42.Source linkedPMID

Recommendation

Take alendronate first thing in the morning with plain water, at least 30 minutes before any food, beverages, or supplements including calcium. Take calcium supplements later in the day, at least 30 minutes after alendronate.

Mechanism

Calcium cations chelate alendronate's bisphosphonate groups, forming insoluble calcium-bisphosphonate complexes. Since alendronate's baseline oral bioavailability is already less than 1%, even small reductions from chelation can eliminate therapeutic drug levels entirely.

• Gertz BJ et al. Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther. 1995;58(3):288-298.Source linkedPMID
• Liu C, Kuang X, Li K, Guo X, Deng Q, Li D. Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. Food & Function. 2020.Source linkedPMID
• Yao P, Bennett D, Mafham M et al.. Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-analysis. JAMA Network Open. 2019.Source linkedPMID

Recommendation

Take alendronate at least 30 minutes before iron supplements. Follow standard alendronate dosing: take with plain water first thing in the morning, remain upright, and avoid all food and supplements for at least 30 minutes.

Mechanism

Iron cations form stable chelate complexes with alendronate's phosphonate groups, creating insoluble iron-bisphosphonate precipitates that cannot be absorbed. This further reduces the drug's already minimal bioavailability.

• Gertz BJ et al. Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther. 1995;58(3):288-298.Source linkedPMID
• Fischer JAJ, Cherian AM, Bone JN, Karakochuk CD. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews. 2023.Source linkedPMID
• Rehman T, Agrawal R, Ahamed F et al.. Optimal dose and duration of iron supplementation for treating iron deficiency anaemia in children and adolescents: A systematic review and meta-analysis. PLoS One. 2025.Source linkedPMID
• Gutema BT, Sorrie MB, Megersa ND et al.. Effects of iron supplementation on cognitive development in school-age children: Systematic review and meta-analysis. PLoS One. 2023.Source linkedPMID

Recommendation

If you take glimepiride, do not start ALA without telling your prescriber. Monitor fingerstick glucose more often (before meals and at bedtime) during the first 4 weeks and seek urgent care for repeated unexplained hypoglycemia.

Mechanism

ALA enhances insulin-stimulated GLUT4 translocation and AMPK activity in skeletal muscle. Its sulfhydryl groups can trigger insulin autoantibody formation in genetically susceptible individuals. Glimepiride binds beta-cell K-ATP channels (SUR1/Kir6.2) and forces insulin secretion. The two effects on glucose-lowering are additive.

• Akbari M, Ostadmohammadi V, Lankarani KB, et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Metabolism. 2018;87:56-69.Source linkedPMID
• Izzo V, Greco C, Corradini D, et al. Insulin autoimmune syndrome in an Argentine woman taking alpha-lipoic acid: A case report and review of the literature. SAGE Open Med Case Rep. 2018;6:2050313X18819601.Source linkedPMID

Recommendation

If you take glipizide, do not start ALA without telling your prescriber. Monitor fingerstick glucose more often during the first 4 weeks and after any dose change. Seek urgent care if you have repeated unexplained hypoglycemia, which can signal insulin autoimmune syndrome.

Mechanism

ALA enhances insulin-stimulated glucose uptake in skeletal muscle by increasing GLUT4 translocation and improving mitochondrial function. ALA's sulfhydryl groups can also bind to insulin and trigger autoantibody formation in genetically susceptible individuals, causing Hirata syndrome. Glipizide drives pancreatic insulin secretion by closing K-ATP channels.

• Akbari M, Ostadmohammadi V, Lankarani KB, et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Metabolism. 2018;87:56-69.Source linkedPMID
• Izzo V, Greco C, Corradini D, et al. Insulin autoimmune syndrome in an Argentine woman taking alpha-lipoic acid: A case report and review of the literature. SAGE Open Med Case Rep. 2018;6:2050313X18819601.Source linkedPMID

Recommendation

Avoid starting ALA on glyburide unless your prescriber agrees and arranges close monitoring. If you do combine them, check fasting and bedtime glucose for at least 4 weeks and seek urgent care for repeated unexplained lows.

Mechanism

ALA enhances insulin-stimulated GLUT4 translocation and AMPK activity, increasing peripheral glucose uptake. Its sulfhydryl groups can also trigger insulin autoantibody formation. Glyburide closes pancreatic beta-cell K-ATP channels to force insulin secretion and accumulates in renal impairment due to its active metabolites.

• Akbari M, Ostadmohammadi V, Lankarani KB, et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Metabolism. 2018;87:56-69.Source linkedPMID
• Sehgal T, Ohri U, Mittal N, et al. A Case of Insulin Autoimmune Syndrome in an Indian Male Taking Alpha-Lipoic Acid. Cureus. 2023;15(7):e42718.Source linkedPMID

Recommendation

Avoid combining passionflower with alprazolam unless your prescriber agrees. If used, start with the lowest possible supplement dose, avoid alcohol and other sedatives, and do not drive until you know the combined effect. Seek urgent help for extreme sleepiness, confusion, falls, or slowed breathing.

Mechanism

Passionflower extracts can produce GABA(A)-related currents and have clinical anxiolytic effects. Alprazolam positively modulates GABA(A) receptors through the benzodiazepine site, creating additive CNS-depressant potential.

• Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363-367.Source linkedPMID
• Elsas SM, Rossi DJ, Raber J, White G, Seeley CA, Gregory WL, et al. Passiflora incarnata L. extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 2010;17(12):940-949.Source linkedPMID

Recommendation

Avoid combining valerian root with alprazolam. If you use valerian for sleep, discontinue it while taking benzodiazepines. Do not drive or operate machinery if using both.

Mechanism

Valerian's valerenic acid and other compounds modulate GABA-A receptor activity, increasing GABAergic inhibitory neurotransmission. Alprazolam is a positive allosteric modulator at GABA-A receptors. Combined GABAergic enhancement causes additive CNS depression.

• Houghton PJ. The scientific basis for the reputed activity of valerian. J Pharm Pharmacol. 1999;51(5):505-512.Source linkedPMID

Recommendation

Monitor ECG closely if combined. Consider alternative antidepressant with lower QT prolongation risk (e.g., sertraline). Keep electrolytes balanced.

Mechanism

Additive QT prolongation through independent hERG potassium channel blockade by both agents.

• Beach SR et al. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics. 2013.Source linkedPMID

Recommendation

Avoid iodine supplements while taking amiodarone unless your prescriber specifically treats a documented deficiency. Follow the thyroid lab schedule your clinician recommends, and report new palpitations, heat or cold intolerance, weight change, tremor, or unusual fatigue.

Mechanism

Excess iodine can trigger Wolff-Chaikoff hypothyroidism or Jod-Basedow thyrotoxicosis in susceptible thyroid tissue. Amiodarone adds iodine exposure and also inhibits thyroid hormone deiodination and can cause direct thyroid cytotoxicity.

• Jabrocka-Hybel A, Bednarczuk T, Bartalena L, et al. Amiodarone and the thyroid. Endokrynol Pol. 2015;66(2):176-186.Source linkedPMID
• Leung AM, Braverman LE. Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):414-419.Source linkedPMID

Recommendation

Maintain adequate magnesium intake while taking amiodarone, especially if you also take diuretics, PPIs, or have diarrhea. Ask your prescriber about checking magnesium periodically, and do not use high-dose magnesium if you have significant kidney disease unless monitored.

Mechanism

Magnesium suppresses early afterdepolarizations and helps maintain intracellular potassium. Hypomagnesemia lowers repolarization reserve, increasing susceptibility to QT-drug-induced torsades.

• Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139-152.Source linkedPMID
• Yau S, Chan P, Sapkin J, Hsieh E. Short-term use of oral amiodarone causing torsades de pointes. Clin Case Rep. 2018;6(8):1554-1556.Source linkedPMID

Recommendation

Keep potassium in the normal range while taking amiodarone, and have levels checked if you use diuretics, have vomiting or diarrhea, or have kidney disease. Do not start potassium tablets or high-dose electrolyte powders unless your prescriber is monitoring your blood potassium.

Mechanism

Amiodarone blocks cardiac potassium currents and prolongs repolarization. Hypokalemia further reduces IKr reserve and promotes early afterdepolarizations, while potassium repletion lowers susceptibility to drug-induced torsades.

• Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139-152.Source linkedPMID
• Yau S, Chan P, Sapkin J, Hsieh E. Short-term use of oral amiodarone causing torsades de pointes. Clin Case Rep. 2018;6(8):1554-1556.Source linkedPMID

Recommendation

Do not combine St. John's Wort with amiodarone. Loss of arrhythmia control can be life-threatening. Discuss alternative mood support options with your cardiologist.

Mechanism

Amiodarone is primarily metabolized by CYP3A4 to its active metabolite desethylamiodarone. St. John's Wort's potent CYP3A4 induction via PXR activation can accelerate amiodarone metabolism, reducing both parent drug and metabolite levels below the therapeutic range.

• Moore LB et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA. 2000;97(13):7500-7502.Source linkedPMID

Recommendation

Avoid alcohol while taking amitriptyline, especially near bedtime doses or before driving. If you drink despite this, keep intake very low and do not drive, operate machinery, or combine with opioids, benzodiazepines, or other sleep aids. Older adults should treat this combination as especially risky.

Mechanism

Ethanol can reduce first-pass hepatic clearance of amitriptyline during absorption, increasing free amitriptyline concentrations. Alcohol also potentiates GABA-A signaling and impairs NMDA signaling, adding CNS depression to amitriptyline's antihistamine, anticholinergic, and alpha-1 blocking effects.

• Dorian P, Sellers EM, Reed KL, et al. Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction. Eur J Clin Pharmacol. 1983;25(3):325-331.Source linkedPMID
• Scott DB, Fagan D, Tiplady B. Effects of amitriptyline and zimelidine in combination with ethanol. Psychopharmacology (Berl). 1982;76(3):209-211.Source linkedPMID
• Brunnauer A, Laux G. Driving Under the Influence of Antidepressants: A Systematic Review and Update of the Evidence of Experimental and Controlled Clinical Studies. Pharmacopsychiatry. 2017;50(5):173-181.Source linkedPMID

Recommendation

Avoid St. John's Wort while taking amitriptyline. If the combination is already in use, do not start or stop St. John's Wort abruptly without a medication plan; your prescriber may need symptom checks, TCA blood levels, or dose adjustment. Watch for relapse when St. John's Wort starts and for TCA side effects when it stops.

Mechanism

St. John's Wort induces CYP3A4 and P-glycoprotein through hyperforin-mediated pregnane X receptor activation. Amitriptyline is metabolized through CYP2C19, CYP2D6, and CYP3A pathways, and the active metabolite nortriptyline is also affected by the interaction.

• Johne A, Schmider J, Brockmoller J, Stadelmann AM, Stormer E, Bauer S, et al. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort (Hypericum perforatum). J Clin Psychopharmacol. 2002;22(1):46-54.Source linkedPMID
• Zhou S, Chan E, Pan SQ, Huang M, Lee EJ. Pharmacokinetic interactions of drugs with St John's wort. J Psychopharmacol. 2004;18(2):262-276.Source linkedPMID
• Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777-1798.Source linkedPMID

Recommendation

Avoid combining St. John's Wort with amlodipine. If currently taking both, consult your prescriber before making changes. Abruptly stopping St. John's Wort could cause amlodipine levels to rise. If blood pressure control is lost, St. John's Wort should be considered as a potential cause.

Mechanism

Hyperforin, the active constituent of St. John's Wort, activates the nuclear pregnane X receptor (PXR), inducing transcription of CYP3A4 and other drug-metabolizing enzymes. This accelerates amlodipine's hepatic and intestinal metabolism, reducing bioavailability and plasma concentrations below therapeutic levels.

• Nicolussi S et al. Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol. 2020;177(6):1212-1226.Source linkedPMID
• Moore LB et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA. 2000;97(13):7500-7502.Source linkedPMID

Recommendation

Avoid alcohol on days you take amphetamine/dextroamphetamine when possible. If you drink, keep intake low, do not drive, and do not take extra stimulant doses to stay alert. Seek care for chest pain, fainting, severe agitation, confusion, or an irregular heartbeat.

Mechanism

Dextroamphetamine increases catecholamine signaling and alertness, while ethanol impairs judgment, coordination, and reaction time through CNS depressant effects. The stimulant can mask perceived impairment without reversing alcohol's cognitive and motor risks, and both can increase cardiovascular workload.

• Perez-Reyes M, White WR, McDonald SA, Hicks RE. Interaction between ethanol and dextroamphetamine: effects on psychomotor performance. Alcohol Clin Exp Res. 1992;16(1):75-81.Source linkedPMID
• Althobaiti YS, Sari Y. Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies. J Addict Res Ther. 2016;7(3):281.Source linkedPMID

Recommendation

Avoid ginkgo biloba while taking apixaban. If you have been combining the two, stop the ginkgo and call your prescriber if you notice unusual bruising, nosebleeds, or any sign of bleeding.

Mechanism

Ginkgolides, particularly ginkgolide B, are potent platelet-activating factor (PAF) antagonists. They inhibit platelet aggregation and prolong bleeding time. This pharmacodynamic effect is additive to apixaban's direct factor Xa inhibition.

• Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657-61.Source linkedPMID
• Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490-502.Source linkedPMID

Recommendation

Avoid combining St. John's Wort with apixaban. The FDA and EMA both list strong CYP3A4 inducers as contraindicated with DOACs. Discuss alternative mood support options with your prescriber.

Mechanism

Hyperforin activates PXR, upregulating CYP3A4 and P-glycoprotein expression. Apixaban is a CYP3A4 substrate and P-gp substrate, so increased metabolism and efflux significantly reduce its bioavailability and plasma concentration.

• Vakkalagadda B et al. Effect of rifampin on the pharmacokinetics of apixaban, a selective factor Xa inhibitor. Am J Ther. 2016;23(2):e460-467.Source linkedPMID
• Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA. 2003;290(11):1500-1504.Source linkedPMID

Recommendation

Avoid THC-dominant cannabis while taking aripiprazole for psychosis or mood stabilization. If you are already using cannabis, tell your prescriber because relapse risk and medication adherence need closer monitoring. Separating the timing of cannabis and aripiprazole does not remove this risk.

Mechanism

THC is a psychoactive cannabinoid that can provoke or worsen psychotic symptoms through CB1 receptor effects on dopaminergic and glutamatergic signaling. Cannabis use also increases the likelihood of missed antipsychotic doses, creating a pharmacodynamic and behavioral conflict with relapse prevention.

• Schoeler T, Monk A, Sami MB, Klamerus E, Foglia E, Brown R, et al. Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3(3):215-225.Source linkedPMID
• Reid S, Bhattacharyya S. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review. Psychiatry Res. 2019;280:112523.Source linkedPMID

Recommendation

Avoid St. John's Wort with aripiprazole. The FDA prescribing information lists strong CYP3A4 inducers as requiring dose adjustment.

Mechanism

Aripiprazole is metabolized by CYP3A4 and CYP2D6. St. John's Wort induces CYP3A4, significantly increasing aripiprazole clearance and reducing therapeutic levels.

• Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA. 2003;290(11):1500-1504.Source linkedPMID
• Belmonte C, Ochoa D, Roman M, et al. Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers. Basic Clin Pharmacol Toxicol. 2018;122(6):596-605.Source linkedPMID

Recommendation

Review all prescription medications for CYP3A4 metabolism before starting artemisinin.

Mechanism

Mechanism-based (irreversible) inhibition of CYP3A4 and CYP2B6 by flavonoid/coumarin components.

• Artemisia annua irreversible CYP3A4/CYP2B6 inhibitionSource linkedPMID
• Obonyo CO, Were VO, Wamae P, Muok EMO. Efficacy and safety of praziquantel plus artemisinin-based combinations versus praziquantel in the treatment of Kenyan children with Schistosoma mansoni infection: open-label, randomized, head-to-head, non-inferiority trial. Antimicrob Agents Chemother. 2025.Source linkedPMID

Recommendation

Avoid heavy alcohol use while taking low-dose aspirin. If you drink, keep intake modest and seek urgent care for black stools, vomiting blood, faintness, or unexplained weakness.

Mechanism

Aspirin irreversibly inhibits platelet COX-1 and suppresses thromboxane A2, reducing platelet aggregation. It also reduces protective gastric prostaglandins; ethanol adds direct mucosal injury and can worsen bleeding from aspirin-related erosions.

• Kaufman DW, Kelly JP, Wiholm BE, Laszlo A, Sheehan JE, Koff RS, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol. 1999;94(11):3189-3196.Source linkedPMID
• Strate LL, Singh P, Boylan MR, Piawah S, Cao Y, Chan AT. A Prospective Study of Alcohol Consumption and Smoking and the Risk of Major Gastrointestinal Bleeding in Men. PLoS One. 2016;11(11):e0165278.Source linkedPMID

Recommendation

Avoid ginkgo biloba while taking aspirin, even at low doses. The combination substantially increases bleeding risk through complementary antiplatelet mechanisms. Inform your prescriber if you use ginkgo supplements.

Mechanism

Aspirin irreversibly inhibits platelet COX-1, reducing thromboxane A2. Ginkgolide B is a potent PAF antagonist that inhibits a separate platelet activation pathway. The combination of COX-1 inhibition and PAF antagonism creates substantial, dual-mechanism platelet inhibition with significant bleeding risk.

• Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology. 1996;46(6):1775-1776.Source linkedPMID
• Mousavi SN, Hosseinikia M, Yousefi Rad E, Saboori S. Beneficial effects of Ginkgo biloba leaf extract on inflammatory markers: A systematic review and meta-analysis of the clinical trials. Phytotherapy Research. 2022.Source linkedPMID
• Tabrizi R, Nowrouzi-Sohrabi P, Hessami K et al.. Effects of Ginkgo biloba intake on cardiometabolic parameters in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Phytotherapy Research. 2020.Source linkedPMID

Recommendation

Avoid cocaine while taking atomoxetine. Do not take extra atomoxetine to offset cocaine crash, fatigue, or attention problems. Seek emergency care for chest pain, severe headache, fainting, severe agitation, shortness of breath, or a fast or irregular heartbeat.

Mechanism

Atomoxetine inhibits the norepinephrine transporter and can increase blood pressure and heart rate. Cocaine blocks norepinephrine, dopamine, and serotonin reuptake, increases sympathetic outflow, causes vasoconstriction, and can impair cardiac conduction through sodium-channel blockade, creating additive cardiovascular and neuropsychiatric toxicity potential.

• Cantilena L, Kahn R, Duncan CC et al.. Safety of atomoxetine in combination with intravenous cocaine in cocaine-experienced participants. Journal of addiction medicine. 2012 Dec;6(4):265-73.Source linkedPMID
• DeVito EE, Herman AI, Konkus NS et al.. Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects. Pharmacology, biochemistry, and behavior. 2017 Aug;159:55-61.Source linkedPMID
• Kim ST, Park T. Acute and Chronic Effects of Cocaine on Cardiovascular Health. International journal of molecular sciences. 2019;20(3):584.Source linkedPMID

Recommendation

Limit atorvastatin to 20 mg daily when used with clarithromycin. Consider azithromycin as alternative macrolide (no CYP3A4 inhibition) or pravastatin/rosuvastatin as alternative statin.

Mechanism

CYP3A4 inhibition by clarithromycin reduces atorvastatin first-pass metabolism, increasing systemic exposure and myotoxicity risk.

• Jacobson TA. Comparative pharmacokinetic interaction profiles of statins. Am J Cardiol. 2004.Source linkedPMID

Recommendation

Avoid large or repeated grapefruit intake while taking atorvastatin; ask your prescriber or pharmacist about your specific dose and risk.

Mechanism

Furanocoumarins in grapefruit inhibit intestinal CYP3A4, reducing first-pass metabolism of atorvastatin.

• Bailey DG et al. Grapefruit juice-drug interactions. Br J Clin Pharmacol. 1998.Source linkedPMID

Recommendation

Avoid combining St. John's Wort with atorvastatin. If mood support is needed, discuss alternative options with your prescriber that do not induce CYP3A4.

Mechanism

Hyperforin in St. John's Wort activates PXR, leading to upregulation of CYP3A4 and P-glycoprotein. Atorvastatin is extensively metabolized by CYP3A4, so enzyme induction dramatically accelerates its clearance and reduces therapeutic plasma concentrations.

• Sugimoto K et al. Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther. 2001;70(6):518-524.Source linkedPMID

Recommendation

Avoid adding Tribulus terrestris to atorvastatin without clinician review. Stop the supplement and seek care urgently for severe muscle pain, weakness, dark urine, or unexplained fever.

Mechanism

The mechanism is uncertain. A published case suggests possible additive myotoxicity or pharmacokinetic interaction, while atorvastatin is already vulnerable to interaction-driven myopathy through CYP3A4 and transporter pathways.

• Huff R, Karpinska-Leydier K, Maddineni G, Begosh-Mayne D. Rhabdomyolysis Risk: The Dangers of Tribulus Terrestris, an Over-the-Counter Supplement. American Journal of Case Reports. 2024;25:e943492.Source linkedPMID
• Balasubramanian R, Maideen NMP. HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview. Current Drug Metabolism. 2021;22(5):328-341.Source linkedPMID

Recommendation

Avoid alcohol while taking baclofen unless your prescriber is deliberately supervising baclofen for alcohol use disorder. Do not drive or operate machinery if you have used both. Report heavy sedation, confusion, fainting, or breathing problems promptly.

Mechanism

Baclofen is a GABA-B receptor agonist that reduces excitatory neurotransmission in the spinal cord and brain. Alcohol also enhances inhibitory signaling and impairs cortical and cerebellar function, producing additive sedation and psychomotor impairment.

• Evans SM, Bisaga A. Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcohol Clin Exp Res. 2009;33(1):19-30.Source linkedPMID
• Rolland B, Labreuche J, Duhamel A, Deheul S, Gautier S, Auffret M, et al. Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation. Eur Neuropsychopharmacol. 2015;25(10):1631-1636.Source linkedPMID

Recommendation

Avoid Lithium Orotate while taking benazepril. If used together, keep the dose low, stay well hydrated, and ask your prescriber to check serum lithium after 1-2 weeks. Hold the supplement during any vomiting, diarrhea, or fever.

Mechanism

ACE inhibition reduces angiotensin II and aldosterone, causing natriuresis and a fall in GFR. Lithium reabsorption in the proximal tubule tracks sodium, so sodium loss and reduced filtration both increase fractional lithium reabsorption.

• Finley PR, O'Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol. 1996;16(1):68-71.Source linkedPMID
• Baldwin CM, Safferman AZ. A case of lisinopril-induced lithium toxicity. DICP. 1990;24(10):946-7.Source linkedPMID

Recommendation

Do not take potassium supplements with benazepril unless your prescriber has confirmed a deficiency and ordered them. If both are required, have potassium levels checked within 1-2 weeks of starting and then periodically. Avoid potassium-based salt substitutes as well.

Mechanism

ACE inhibition reduces angiotensin II-driven aldosterone secretion at the adrenal zona glomerulosa, decreasing potassium excretion at the cortical collecting duct. Exogenous potassium then accumulates because renal handling is impaired.

• Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med. 1998;158(1):26-32.Source linkedPMID
• Mann JF, Yi QL, Sleight P, Dagenais GR, Gerstein HC, Lonn EM, Bosch J; HOPE Investigators. Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study. Clin Nephrol. 2005;63(3):181-7.Source linkedPMID

Recommendation

Avoid combining berberine with verapamil. If your clinician approves co-use, monitor pulse and blood pressure daily for the first 2 weeks, and report HR below 50 bpm, dizziness, or new constipation. Separate doses by at least 4 hours to limit intestinal interaction.

Mechanism

Berberine inhibits CYP3A4 (the main verapamil-metabolizing enzyme) and intestinal P-gp. Bidirectionally, verapamil inhibits P-gp-mediated efflux of berberine, raising its plasma levels.

• Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-7.Source linkedPMID
• Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol. 2002;91(4):193-7.Source linkedPMID

Recommendation

Avoid combining without medical supervision and digoxin level monitoring. Risk of digoxin toxicity.

Mechanism

P-glycoprotein inhibition reduces intestinal efflux of digoxin, increasing absorption.

• Berberine drug interaction profileSource linkedPMID

Recommendation

Do not add Berberine HCl to glipizide without a glucose-monitoring plan. Check glucose more often for the first 1-2 weeks and ask your prescriber whether glipizide dose reduction is appropriate if readings fall.

Mechanism

Berberine improves glucose disposal and insulin sensitivity through AMPK-linked pathways. Glipizide closes pancreatic beta-cell KATP channels and increases insulin release, creating additive pharmacodynamic glucose lowering.

• Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717.Source linkedPMID
• Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045.Source linkedPMID

Recommendation

Avoid adding Berberine HCl to glyburide unless your prescriber is supervising glucose monitoring. Check glucose more frequently when starting or stopping Berberine HCl, and have a plan for treating low blood sugar.

Mechanism

Berberine improves glucose metabolism through AMPK-related pathways, while glyburide increases insulin secretion by blocking beta-cell KATP channels. The combined pharmacodynamic effect can produce excessive glucose lowering.

• Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717.Source linkedPMID
• Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045.Source linkedPMID

Recommendation

Do not change Berberine HCl use without tracking pre-meal and post-meal glucose if you use insulin aspart. Ask your diabetes clinician whether insulin-to-carbohydrate ratios or correction doses need adjustment.

Mechanism

Berberine improves insulin sensitivity and glucose disposal through AMPK-related pathways. These effects can add to rapid-acting insulin-mediated peripheral glucose uptake after meals.

• Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717.Source linkedPMID
• Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045.Source linkedPMID

Recommendation

Use Berberine HCl with insulin glargine only with a glucose-monitoring plan. Check fasting and overnight-risk readings more often after any Berberine HCl change and ask whether basal insulin dose adjustment is needed.

Mechanism

Berberine improves insulin sensitivity and glucose uptake through AMPK-linked effects. Those effects add to exogenous basal insulin action, increasing the chance that hepatic glucose output and peripheral glucose availability fall too far.

• Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717.Source linkedPMID
• Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045.Source linkedPMID

Recommendation

If you use insulin lispro, start or stop Berberine HCl only with extra glucose monitoring. Review low readings with your diabetes clinician before changing insulin doses.

Mechanism

Berberine improves glucose uptake and insulin sensitivity through AMPK-linked pathways. These actions can add to insulin lispro's rapid insulin receptor-mediated glucose disposal after meals.

• Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717.Source linkedPMID
• Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045.Source linkedPMID

Recommendation

If combining, increase INR monitoring frequency.

Mechanism

Dual mechanism: albumin binding displacement + CYP2C9 inhibition.

• Berberine drug interaction profileSource linkedPMID
• Wang M, Zeraatkar D, Obeda M, Lee M et al.. Drug-drug interactions with warfarin: A systematic review and meta-analysis. British Journal of Clinical Pharmacology. 2021.Source linkedPMID

Recommendation

Avoid combining St. John's Wort with bupropion due to increased seizure risk. If mood support beyond bupropion is needed, discuss evidence-based augmentation strategies with your prescriber.

Mechanism

Bupropion inhibits dopamine and norepinephrine reuptake and is known to lower seizure threshold in a dose-dependent manner. St. John's Wort affects multiple neurotransmitter systems including inhibiting serotonin, norepinephrine, and dopamine reuptake. The combined neuroexcitatory effects may further reduce seizure threshold.

• Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clin Ther. 2005;27(11):1685-1695.Source linkedPMID
• Linde K et al. St John's wort for major depression. Cochrane Database Syst Rev. 2008;(4):CD000448.Source linkedPMID

Recommendation

Avoid concentrated 5-HTP supplements while taking buspirone unless your prescriber specifically approves the combination. Do not try to manage this by dose spacing alone. Seek urgent care if you develop fever, confusion, marked restlessness, tremor, muscle rigidity, or repeated muscle jerks after taking both.

Mechanism

5-HTP is decarboxylated by aromatic L-amino acid decarboxylase to serotonin, increasing serotonin synthesis. Buspirone is a serotonin 5-HT1A partial agonist, so combined exposure can overstimulate serotonergic pathways in susceptible patients.

• Manos GH. Possible serotonin syndrome associated with buspirone added to fluoxetine. Ann Pharmacother. 2000;34(7-8):871-874.Source linkedPMID
• Maffei ME. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int J Mol Sci. 2020;22(1):181.Source linkedPMID
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Avoid high-dose L-Tryptophan supplements while taking buspirone unless your prescriber is deliberately supervising the combination. Normal protein foods are not the concern; concentrated sleep or mood products are. Seek urgent care for fever, confusion, tremor, diarrhea, sweating, or muscle jerks after overlap.

Mechanism

L-Tryptophan crosses the blood-brain barrier and supplies substrate for tryptophan hydroxylase, the rate-limiting step in serotonin synthesis. Buspirone activates 5-HT1A receptors, creating a plausible pharmacodynamic stacking risk when serotonin precursor availability is pushed upward.

• Manos GH. Possible serotonin syndrome associated with buspirone added to fluoxetine. Ann Pharmacother. 2000;34(7-8):871-874.Source linkedPMID
• Richard DM, Dawes MA, Mathias CW, Acheson A, Hill-Kapturczak N, Dougherty DM. L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. Int J Tryptophan Res. 2009;2:45-60.Source linkedPMID
• Pope HG, Jonas JM, Hudson JI, Kafka MP. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan. Am J Psychiatry. 1985;142(4):491-492.Source linkedPMID

Recommendation

Avoid St. John's Wort while taking buspirone unless your prescriber specifically directs otherwise. Do not use dose spacing as a workaround because both serotonergic effects and enzyme induction can persist. Seek urgent care for fever, confusion, tremor, sweating, diarrhea, muscle rigidity, or clonus.

Mechanism

St. John's Wort contains hyperforin and other constituents that affect monoamine signaling and induce CYP3A/P-glycoprotein through pregnane X receptor activation. Buspirone is a serotonergic 5-HT1A partial agonist and a CYP3A substrate, so the combination can create both pharmacodynamic serotonin-toxicity risk and pharmacokinetic unpredictability.

• Dannawi M. Possible serotonin syndrome after combination of buspirone and St John's Wort. J Psychopharmacol. 2002;16(4):401.Source linkedPMID
• Nicolussi S, Drewe J, Butterweck V, Meyer Zu Schwabedissen HE. Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol. 2020;177(6):1212-1226.Source linkedPMID
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID

Recommendation

Do not combine. The mix sharply increases impairment and accident risk; do not drive or operate machinery, and seek medical advice if severe vomiting, confusion, or loss of consciousness occurs.

Mechanism

Alcohol can increase THC absorption and both act as CNS depressants, producing additive impairment of cognition, coordination, and reaction time along with cardiovascular and gastrointestinal effects.

• Hartman RL et al. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol. Clin Chem. 2015;61(6):850-69.Source linkedPMID
• Downey LA et al. The effects of cannabis and alcohol on simulated driving: Influences of dose and experience. Accid Anal Prev. 2013;50:879-86.Source linkedPMID

Recommendation

Avoid ginkgo biloba if you take carbamazepine for epilepsy or have any seizure history. If you already started ginkgo and notice breakthrough seizures, auras, twitching, confusion spells, or loss of awareness, stop it and seek medical advice urgently. Do not change carbamazepine dosing without your prescriber.

Mechanism

Ginkgo products may lower seizure threshold; ginkgotoxin can antagonize vitamin B6-dependent GABA synthesis, and some reports also raise concern for herb-drug effects on antiseizure medication exposure. This pharmacodynamic seizure-threshold effect can oppose carbamazepine's sodium-channel antiseizure activity.

• Granger AS. Ginkgo biloba precipitating epileptic seizures. Age Ageing. 2001;30(6):523-525.Source linkedPMID
• Kupiec T, Raj V. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Anal Toxicol. 2005;29(7):755-758.Source linkedPMID

Recommendation

Avoid combining St. John's Wort with carbamazepine. The dual CYP induction creates unpredictable drug levels and may compromise seizure control. Monitor carbamazepine levels closely if the combination cannot be avoided.

Mechanism

Carbamazepine is both a CYP3A4 substrate and inducer (auto-induction). St. John's Wort additionally induces CYP3A4 via PXR activation. The combined induction can accelerate carbamazepine metabolism beyond its auto-induction plateau, potentially reducing levels below the therapeutic range.

• Burstein AH et al. Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther. 2000;68(6):605-612.Source linkedPMID

Recommendation

Avoid concurrent use.

Mechanism

Potent CYP3A4 inhibition plus PXR activation creates complex drug metabolism effects.

• Cat's claw CYP3A4 inhibitionSource linkedPMID
• Cat's claw protease inhibitor interactionSource linkedPMID

Recommendation

Avoid nattokinase if you take celecoxib with aspirin or other blood-thinning medicines. Stop nattokinase before procedures unless your clinician has specifically approved continued use.

Mechanism

Nattokinase can potentiate fibrinolysis and alter coagulation profiles. Celecoxib inhibits COX-2 and can still produce GI injury, so clot-destabilizing supplements can become clinically relevant in higher-risk settings.

• Kurosawa Y, Nirengi S, Homma T, Esaki K, Ohta M, Clark JF, et al. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Sci Rep. 2015;5:11601.Source linkedPMID
• Jang JY, Kim TS, Cai J, Kim J, Kim Y, Shin K, et al. Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation. Lab Anim Res. 2013;29(4):221-225.Source linkedPMID

Recommendation

Do not add potassium supplements to celecoxib without a reason and a monitoring plan. Check serum potassium and kidney function if you need both, and avoid celecoxib during dehydration unless your clinician advises otherwise.

Mechanism

COX-2 inhibition in the kidney can reduce prostaglandin-mediated renin release and alter aldosterone-dependent potassium excretion. Supplemental potassium can then accumulate when renal reserve is limited.

• Kim GH. Renal effects of prostaglandins and cyclooxygenase-2 inhibitors. Electrolyte Blood Press. 2008;6(1):35-41.Source linkedPMID
• Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and management of hyperkalemia. Pediatr Nephrol. 2011;26(3):377-384.Source linkedPMID

Recommendation

Avoid while on warfarin, or maintain very consistent intake with INR monitoring.

Mechanism

Vitamin K content opposes warfarin's inhibition of vitamin K-dependent clotting factors.

• Chlorella warfarin interaction case reportSource linkedPMID
• Sanayei M, Izadi A, Hajizadeh-Sharafabad F et al.. Chlorella vulgaris in combination with high intensity interval training in overweight and obese women: a randomized double-blind clinical trial. Journal of Diabetes and Metabolic Disorders. 2021.Source linkedPMID
• Wang M, Zeraatkar D, Obeda M, Lee M et al.. Drug-drug interactions with warfarin: A systematic review and meta-analysis. British Journal of Clinical Pharmacology. 2021.Source linkedPMID

Recommendation

Avoid starting chromium on glyburide unless your prescriber agrees. If you do combine them, monitor fasting and bedtime glucose closely for the first month and ask whether glyburide should be reduced or switched to a shorter-acting sulfonylurea.

Mechanism

Chromium amplifies insulin receptor signaling and GLUT4 translocation in muscle, while glyburide closes pancreatic beta-cell K-ATP channels to force insulin secretion. The combined effect lowers glucose more than either alone. Glyburide's active metabolites also accumulate in renal impairment, prolonging the hypoglycemic effect.

• Singer GM, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther. 2006;8(6):636-43.Source linkedPMID
• Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2-14.Source linkedPMID

Recommendation

Take ciprofloxacin at least 2 hours before or 6 hours after any aluminum or magnesium hydroxide antacid. Do not co-administer in the same dose.

Mechanism

Polyvalent cations (Al3+, Mg2+) bind to the 4-oxo and 3-carboxyl groups on the fluoroquinolone ring, forming nonabsorbable chelate complexes in the small intestine and blocking enterocyte uptake.

• Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929-6932.Source linkedPMID
• Sultana N, Arayne MS, Hussain F. In vitro monitoring of ciprofloxacin antacids interactions by UV & HPLC. Pak J Pharm Sci. 2005;18(4):23-31.Source linkedPMID
• Wiesner A, Zagrodzki P, Gawalska A, Paśko P. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses. Clin Pharmacokinet. 2024;63(6):773-818.Source linkedPMID

Recommendation

Separate ciprofloxacin and calcium supplements by at least 2 hours (take ciprofloxacin 2 hours before or 6 hours after calcium). This timing separation is critical for maintaining antibiotic efficacy.

Mechanism

Calcium divalent cations form insoluble chelate complexes with ciprofloxacin's 4-oxo and 3-carboxyl groups, which are essential for both antibacterial activity and GI absorption. The chelated complex is not absorbed and is excreted in feces.

• Lomaestro BM, Bailie GR. Absorption interactions with fluoroquinolones. Drug Saf. 1995;12(5):314-333.Source linkedPMID
• Alves C, Mendes D, Marques FB. Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis.. European Journal of Clinical Pharmacology. 2019.Source linkedPMID
• Liu C, Kuang X, Li K, Guo X, Deng Q, Li D. Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. Food & Function. 2020.Source linkedPMID
• Yao P, Bennett D, Mafham M et al.. Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-analysis. JAMA Network Open. 2019.Source linkedPMID

Recommendation

Take ciprofloxacin at least 2 hours before or 6 hours after calcium carbonate. Avoid taking with calcium-fortified drinks or dairy in the same window.

Mechanism

Ca2+ cations form insoluble chelates with the 3-carboxyl and 4-oxo groups of the fluoroquinolone core, preventing intestinal absorption.

• Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929-6932.Source linkedPMID
• Wiesner A, Zagrodzki P, Gawalska A, Paśko P. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses. Clin Pharmacokinet. 2024;63(6):773-818.Source linkedPMID

Recommendation

Separate ciprofloxacin and iron supplements by at least 2 hours (take ciprofloxacin 2 hours before or 6 hours after iron). Do not take them together under any circumstances during active antibiotic treatment.

Mechanism

Iron (Fe2+/Fe3+) forms tight chelate complexes with ciprofloxacin's keto-carboxylate moiety. Iron is one of the most potent chelators of fluoroquinolones, reducing bioavailability by 30-90% depending on the iron dose and formulation.

• Polk RE et al. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother. 1989;33(11):1841-1844.Source linkedPMID
• Alves C, Mendes D, Marques FB. Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis.. European Journal of Clinical Pharmacology. 2019.Source linkedPMID
• Fischer JAJ, Cherian AM, Bone JN, Karakochuk CD. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews. 2023.Source linkedPMID
• Rehman T, Agrawal R, Ahamed F et al.. Optimal dose and duration of iron supplementation for treating iron deficiency anaemia in children and adolescents: A systematic review and meta-analysis. PLoS One. 2025.Source linkedPMID

Recommendation

Take ciprofloxacin at least 2 hours before or 6 hours after any iron supplement, including bisglycinate. Do not take together in the same dose.

Mechanism

Fe2+ and Fe3+ cations chelate the 3-carboxyl and 4-oxo groups of ciprofloxacin, forming insoluble complexes that are not absorbed across enterocytes.

• Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions. Br J Clin Pharmacol. 1991;31(3):251-5.Source linkedPMID
• Polk RE. Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am J Med. 1989;87(5A):76S-81S.Source linkedPMID
• Wiesner A, Zagrodzki P, Gawalska A, Paśko P. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses. Clin Pharmacokinet. 2024;63(6):773-818.Source linkedPMID

Recommendation

Take ciprofloxacin at least 2 hours before or 6 hours after magnesium citrate. Do not co-administer in the same dose.

Mechanism

Mg2+ cations chelate the 3-carboxyl and 4-oxo groups on ciprofloxacin, forming insoluble complexes in the intestinal lumen that are not absorbed.

• Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929-6932.Source linkedPMID
• Wiesner A, Zagrodzki P, Gawalska A, Paśko P. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses. Clin Pharmacokinet. 2024;63(6):773-818.Source linkedPMID

Recommendation

Separate ciprofloxacin and magnesium supplements by at least 2 hours (take ciprofloxacin 2 hours before or 6 hours after magnesium). This includes magnesium-containing antacids and laxatives.

Mechanism

Magnesium divalent cations chelate ciprofloxacin via the 4-oxo-3-carboxylic acid group, forming an insoluble complex that cannot be absorbed across the intestinal mucosa. The binding affinity is high enough to render the antibiotic inactive.

• Lomaestro BM, Bailie GR. Absorption interactions with fluoroquinolones. Drug Saf. 1995;12(5):314-333.Source linkedPMID
• Alves C, Mendes D, Marques FB. Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis.. European Journal of Clinical Pharmacology. 2019.Source linkedPMID
• Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis.. BMC Complementary Medicine and Therapies. 2021.Source linkedPMID
• Veronese N, Dominguez LJ, Pizzol D et al.. Oral Magnesium Supplementation for Treating Glucose Metabolism Parameters in People with or at Risk of Diabetes: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.. Nutrients. 2021.Source linkedPMID

Recommendation

Take ciprofloxacin at least 2 hours before or 6 hours after magnesium L-threonate. Do not combine in the same dose.

Mechanism

Mg2+ released from magnesium L-threonate chelates the 3-carboxyl and 4-oxo groups on the fluoroquinolone core, forming insoluble complexes that block enterocyte absorption.

• Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929-6932.Source linkedPMID
• Wiesner A, Zagrodzki P, Gawalska A, Paśko P. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses. Clin Pharmacokinet. 2024;63(6):773-818.Source linkedPMID

Recommendation

Take ciprofloxacin at least 2 hours before or 6 hours after magnesium malate. Do not co-administer.

Mechanism

Mg2+ from magnesium malate chelates the 3-carboxyl and 4-oxo groups on the fluoroquinolone core, forming insoluble complexes that block enterocyte uptake.

• Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929-6932.Source linkedPMID
• Wiesner A, Zagrodzki P, Gawalska A, Paśko P. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses. Clin Pharmacokinet. 2024;63(6):773-818.Source linkedPMID

Recommendation

Take ciprofloxacin at least 2 hours before or 6 hours after magnesium taurate. Do not co-administer.

Mechanism

Mg2+ from magnesium taurate chelates the 3-carboxyl and 4-oxo groups on the fluoroquinolone core, forming insoluble complexes that block intestinal absorption.

• Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929-6932.Source linkedPMID
• Wiesner A, Zagrodzki P, Gawalska A, Paśko P. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses. Clin Pharmacokinet. 2024;63(6):773-818.Source linkedPMID

Recommendation

Separate manganese supplements from ciprofloxacin by at least 2 hours, and follow any stricter antibiotic instructions from your prescriber or pharmacist. Avoid taking ciprofloxacin with mineral stacks, multivitamins, or antacids. Contact your clinician if infection symptoms worsen or fail to improve.

Mechanism

Ciprofloxacin chelates multivalent metal cations through quinolone functional groups, forming less absorbable complexes in the gut. Manganese is a multivalent cation and has demonstrated complex formation with ciprofloxacin under clinically relevant test conditions.

• Hosono M, Yokoyama H, Takayanagi R, Yamada Y. Interactions between new quinolone antibacterials and diagnostic drug containing manganese. Eur J Drug Metab Pharmacokinet. 2013;38(4):255-259.Source linkedPMID
• Polk RE, Healy DP, Sahai J, Drwal L, Racht E. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother. 1989;33(11):1841-1844.Source linkedPMID
• Deppermann KM, Lode H. Fluoroquinolones: interaction profile during enteral absorption. Drugs. 1993;45 Suppl 3:65-72.Source linkedPMID

Recommendation

Separate ciprofloxacin and zinc supplements by at least 2 hours (take ciprofloxacin 2 hours before or 6 hours after zinc). Check multivitamin labels for zinc content and separate accordingly.

Mechanism

Zinc divalent cations form stable chelate complexes with ciprofloxacin's keto-carboxylate moiety. The resulting zinc-ciprofloxacin complex has poor aqueous solubility and cannot be absorbed in the intestine.

• Polk RE et al. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother. 1989;33(11):1841-1844.Source linkedPMID
• Alves C, Mendes D, Marques FB. Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis.. European Journal of Clinical Pharmacology. 2019.Source linkedPMID
• Hsu TJ, Hsieh RH, Huang CH et al.. Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.. Nutrients. 2024.Source linkedPMID
• Ali AA, Naqvi SK, Hasnain Z et al.. Zinc supplementation for acute and persistent watery diarrhoea in children: A systematic review and meta-analysis.. Journal of Global Health. 2024.Source linkedPMID

Recommendation

Take ciprofloxacin at least 2 hours before or 6 hours after zinc carnosine. Do not co-administer.

Mechanism

Zn2+ chelates the 3-carboxyl and 4-oxo groups on the fluoroquinolone core, forming nonabsorbable complexes in the intestinal lumen.

• Polk RE. Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am J Med. 1989;87(5A):76S-81S.Source linkedPMID
• Wiesner A, Zagrodzki P, Gawalska A, Paśko P. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses. Clin Pharmacokinet. 2024;63(6):773-818.Source linkedPMID

Recommendation

Take ciprofloxacin at least 2 hours before or 6 hours after zinc picolinate. Do not take in the same dose.

Mechanism

Zn2+ chelates the 3-carboxyl and 4-oxo groups on the fluoroquinolone core, forming nonabsorbable complexes in the intestinal lumen.

• Polk RE. Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am J Med. 1989;87(5A):76S-81S.Source linkedPMID
• Wiesner A, Zagrodzki P, Gawalska A, Paśko P. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses. Clin Pharmacokinet. 2024;63(6):773-818.Source linkedPMID

Recommendation

Use the lowest effective melatonin dose if you take citalopram, and avoid adding melatonin when other sedating medicines are already in the stack unless your prescriber approves it. Do not drive or use machinery after starting or increasing melatonin until you know how the combination affects you. Seek urgent care for extreme sleepiness, confusion, fainting, or slow breathing.

Mechanism

The published case suggested product-dependent CYP inhibition by melatonin products, including CYP1A2, CYP2C19, and CYP3A7, with possible effects on citalopram exposure. Citalopram is clinically sensitive to pharmacokinetic interactions involving CYP pathways, and melatonin can also add pharmacodynamic sleep-promoting effects.

• Foster BC, Cvijovic K, Boon HS, Tam TW, Liu R, Murty M, Vu D, Jaeger W, Tsuyuki RT, Barnes J, Vohra S. Melatonin Interaction Resulting in Severe Sedation. J Pharm Pharm Sci. 2015;18(2):124-131.Source linkedPMID
• Spina E, Santoro V, D'Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther. 2008;30(7):1206-1227.Source linkedPMID

Recommendation

Do not start SAMe alongside citalopram without explicit prescriber approval. If used together, start SAMe at the lowest dose and watch for tremor, restlessness, sweating, or rapid heart rate.

Mechanism

SAMe modulates monoamine neurotransmission with measurable antidepressant activity. Combined with citalopram's SERT blockade, additive serotonergic activity can drive postsynaptic toxicity.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20.Source linkedPMID
• Sarris J, Murphy J, Mischoulon D, et al. Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial. Eur Neuropsychopharmacol. 2018;28(10):1126-1136.Source linkedPMID

Recommendation

Avoid St. John's Wort during clarithromycin therapy and for at least 2 weeks before starting. Use an alternative antibiotic or alternative antidepressant strategy if both are needed.

Mechanism

Hyperforin in St. John's Wort activates the pregnane X receptor (PXR), upregulating hepatic and intestinal CYP3A4 and P-glycoprotein. This dramatically accelerates clarithromycin clearance and can lower plasma concentrations below the minimum inhibitory concentration for target organisms.

• Kakuda TN, Schöller-Gyüre M, Hoetelmans RM. Pharmacokinetic interactions between etravirine and non-antiretroviral drugs. Clin Pharmacokinet. 2011;50(1):25-39.Source linkedPMID
• Klotz U. Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonist. Arzneimittelforschung. 2002;52(3):155-61.Source linkedPMID

Recommendation

Do not add passionflower to clonazepam without prescriber guidance. If the combination is approved, avoid driving or hazardous work until you know the effect and stop the supplement if excessive sleepiness, confusion, unsteady gait, or falls occur. Seek urgent care for severe sedation or breathing problems.

Mechanism

Passionflower extract has demonstrated GABA(A)-linked activity and clinical anxiolytic effects. Clonazepam enhances GABA(A) receptor signaling, so the combination can produce additive CNS depression.

• Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363-367.Source linkedPMID
• Elsas SM, Rossi DJ, Raber J, White G, Seeley CA, Gregory WL, et al. Passiflora incarnata L. extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 2010;17(12):940-949.Source linkedPMID

Recommendation

Avoid combining. If using valerian, do not take with clonazepam. Additive sedation can be dangerous.

Mechanism

Clonazepam binds benzodiazepine site on GABA-A receptors. Valerenic acid also modulates GABA-A. Dual allosteric modulation causes excessive CNS depression.

• Spinella M. The importance of pharmacological synergy in psychoactive herbal medicines. Altern Med Rev. 2002;7(2):130-137.Source linkedPMID

Recommendation

Avoid ginkgo biloba while taking clopidogrel. The additive antiplatelet effect creates a serious bleeding risk. If you are taking ginkgo, inform your cardiologist and discontinue it.

Mechanism

Clopidogrel irreversibly blocks P2Y12 receptors, and ginkgolide B antagonizes platelet-activating factor (PAF). The combination inhibits platelets through two independent pathways, creating significantly greater platelet inhibition than either agent alone and substantially increasing bleeding risk.

• Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med. 1997;336(15):1108.Source linkedPMID
• Lun R, Dhaliwal S, Zitikyte G, Roy DC et al.. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis. JAMA Neurology. 2022.Source linkedPMID
• Mousavi SN, Hosseinikia M, Yousefi Rad E, Saboori S. Beneficial effects of Ginkgo biloba leaf extract on inflammatory markers: A systematic review and meta-analysis of the clinical trials. Phytotherapy Research. 2022.Source linkedPMID
• Tabrizi R, Nowrouzi-Sohrabi P, Hessami K et al.. Effects of Ginkgo biloba intake on cardiometabolic parameters in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Phytotherapy Research. 2020.Source linkedPMID

Recommendation

Avoid self-prescribing St. John's Wort with clopidogrel. While it may enhance clopidogrel activation, the unpredictable magnitude of increased antiplatelet effect raises bleeding risk. If your prescriber has identified clopidogrel hyporesponsiveness, discuss this potential interaction with them rather than self-managing with St. John's Wort.

Mechanism

Clopidogrel is a prodrug requiring two-step hepatic activation, primarily by CYP2C19 and CYP3A4. St. John's Wort's hyperforin induces both enzymes via PXR activation, potentially increasing conversion of clopidogrel to its active thiol metabolite. A clinical study confirmed increased CYP3A4 activity and enhanced platelet inhibition with concurrent St. John's Wort.

• Lau WC et al. The effect of St John's Wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity. J Cardiovasc Pharmacol. 2011;57(1):86-93.Source linkedPMID
• Lun R, Dhaliwal S, Zitikyte G, Roy DC et al.. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis. JAMA Neurology. 2022.Source linkedPMID

Recommendation

Do not combine. The two together place additive strain on the heart and coronary arteries. Seek medical advice for stimulant use and stop if chest pain or palpitations occur.

Mechanism

Both are sympathomimetic: cocaine blocks catecholamine reuptake and nicotine triggers catecholamine release, producing additive coronary vasoconstriction, tachycardia, and increased myocardial oxygen demand.

• Moliterno DJ et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med. 1994;330(7):454-9.Source linkedPMID

Recommendation

Avoid alcohol while taking cyclobenzaprine. If alcohol was used, do not drive, operate tools, or take extra sedatives that day. Contact your prescriber if you need muscle spasm treatment but cannot reliably avoid alcohol.

Mechanism

Cyclobenzaprine is a centrally acting skeletal muscle relaxant with sedating and anticholinergic effects. Alcohol adds central nervous system depression and psychomotor impairment, increasing the net effect on alertness, balance, and reaction time.

• Witenko C, Moorman-Li R, Motycka C, Duane K, Hincapie-Castillo J, Leonard P, et al. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. P T. 2014;39(6):427-435.Source linkedPMID
• Elder NC. Abuse of skeletal muscle relaxants. Am Fam Physician. 1991;44(4):1223-1226.Source linkedPMID

Recommendation

Avoid ginkgo biloba while taking dabigatran. If you have been combining them, stop the ginkgo and call your prescriber if you notice unusual bruising, nosebleeds, or any sign of bleeding.

Mechanism

Ginkgolides (notably ginkgolide B) are PAF antagonists that inhibit platelet aggregation and prolong bleeding time. This pharmacodynamic effect is additive to dabigatran's direct thrombin inhibition.

• Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657-61.Source linkedPMID
• Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490-502.Source linkedPMID

Recommendation

Avoid St. John's wort entirely while taking dabigatran. If you have been taking both, do not stop the dabigatran but stop the St. John's wort and tell your prescriber so dabigatran levels and clinical response can be reassessed.

Mechanism

Hyperforin in St. John's wort activates the pregnane X receptor, inducing intestinal P-glycoprotein. Dabigatran etexilate is a P-gp substrate, and P-gp induction reduces its intestinal absorption. Studies with the model P-gp inducer rifampin show ~66% reduction in dabigatran AUC, and St. John's wort is expected to produce a similar effect.

• Nicolussi S, Drewe J, Butterweck V, Meyer Zu Schwabedissen HE. Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol. 2020;177(6):1212-1226.Source linkedPMID
• Härtter S, Sennewald R, Nehmiz G, Reilly P. Oral bioavailability of dabigatran etexilate (Pradaxa(®)) after co-medication with verapamil in healthy subjects. Br J Clin Pharmacol. 2013;75(4):1053-62. (DOAC P-gp mediated DDIs context.)Source linkedPMID

Recommendation

Do not use vitamin C to mask blue lips, gray skin, shortness of breath, severe fatigue, or low oxygen readings while on dapsone. Seek urgent care for those symptoms because methemoglobin levels may need measurement and medical treatment. If you take routine vitamin C, keep the dose modest unless your clinician directs otherwise.

Mechanism

Dapsone is metabolized to hydroxylamine derivatives that oxidize hemoglobin iron from ferrous to ferric state, forming methemoglobin. Ascorbic acid can nonenzymatically reduce methemoglobin and counter oxidative stress, but clinically meaningful effects usually require medical-dose therapy.

• Ward KE, McCarthy MW. Dapsone-induced methemoglobinemia. Ann Pharmacother. 1998;32(5):549-553.Source linkedPMID
• Park SY, Lee KW, Kang TS. High-dose vitamin C management in dapsone-induced methemoglobinemia. Am J Emerg Med. 2014;32(6):684.e1-684.e3.Source linkedPMID
• Kang C, Kim DH, Kim T, et al. Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats. Clin Exp Emerg Med. 2018;5(3):192-198.Source linkedPMID

Recommendation

Avoid St. John's Wort while dexamethasone effect is clinically important unless your prescriber specifically approves. Tell your clinician if you recently started or stopped St. John's Wort because steroid response may change over days to weeks.

Mechanism

High-hyperforin St. John's Wort induces CYP3A4 expression and activity. Dexamethasone is metabolized by CYP3A4, so induction can plausibly increase dexamethasone clearance and lower exposure.

• Whitten DL, Myers SP, Hawrelak JA, Wohlmuth H. The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials. Br J Clin Pharmacol. 2006;62(5):512-526.Source linkedPMID
• Varis T, Kivisto KT, Backman JT, Neuvonen PJ. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Clin Pharmacol Ther. 2000;68(5):487-494.Source linkedPMID

Recommendation

Avoid combining. Abrupt reduction in diazepam levels can cause withdrawal symptoms or seizures.

Mechanism

Diazepam is metabolized by CYP3A4 and CYP2C19 to active metabolites. SJW induces both enzymes, accelerating diazepam clearance and reducing therapeutic levels.

• Markowitz JS et al. Effect of St John's wort on drug metabolism by induction of CYP3A4. JAMA. 2003;290(11):1500-1504.Source linkedPMID

Recommendation

Avoid combining valerian with diazepam. The additive sedative effect can impair breathing and cause excessive drowsiness.

Mechanism

Diazepam binds the benzodiazepine allosteric site on GABA-A receptors. Valerenic acid modulates GABA-A receptors at a different site. Dual enhancement of GABAergic transmission causes excessive inhibition.

• Spinella M. Pharmacological synergy in psychoactive herbal medicines. Altern Med Rev. 2002;7(2):130-137.Source linkedPMID

Recommendation

Avoid heavy alcohol use while taking diclofenac. Use the lowest effective dose for the shortest time and seek care promptly for black stools, vomiting blood, severe stomach pain, or faintness.

Mechanism

Diclofenac inhibits COX-mediated prostaglandin synthesis, weakening gastric mucosal defense. Ethanol adds mucosal irritation and can worsen bleeding from NSAID-associated erosions or ulcers.

• Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35(12):1127-1146.Source linkedPMID
• Strate LL, Singh P, Boylan MR, Piawah S, Cao Y, Chan AT. A Prospective Study of Alcohol Consumption and Smoking and the Risk of Major Gastrointestinal Bleeding in Men. PLoS One. 2016;11(11):e0165278.Source linkedPMID

Recommendation

Avoid ginkgo while using diclofenac regularly. If you continue both, use the lowest diclofenac exposure possible and seek care for black stools, vomiting blood, severe headache, or unusual bruising.

Mechanism

Ginkgo may inhibit platelet activation, while diclofenac reduces protective gastric prostaglandins through COX inhibition. The combined effect can lower hemostatic reserve and increase bleeding from NSAID-related mucosal injury.

• Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657-661.Source linkedPMID
• Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35(12):1127-1146.Source linkedPMID

Recommendation

Avoid nattokinase while using diclofenac regularly. Stop nattokinase before surgery or dental procedures unless your clinician specifically directs otherwise.

Mechanism

Nattokinase can enhance thrombolytic and anticoagulant profiles, while diclofenac inhibits COX-mediated prostaglandins and can damage GI mucosa. These effects can converge on a higher bleeding burden.

• Kurosawa Y, Nirengi S, Homma T, Esaki K, Ohta M, Clark JF, et al. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Sci Rep. 2015;5:11601.Source linkedPMID
• Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35(12):1127-1146.Source linkedPMID

Recommendation

Avoid potassium supplements during repeated diclofenac use unless your clinician is monitoring potassium and kidney function. Stop diclofenac and seek advice during vomiting, diarrhea, poor intake, or dehydration.

Mechanism

Diclofenac blocks renal prostaglandin production, which can suppress renin and aldosterone and reduce potassium secretion in the distal nephron. Supplemental potassium increases the filtered and extracellular potassium load.

• Kim GH. Renal effects of prostaglandins and cyclooxygenase-2 inhibitors. Electrolyte Blood Press. 2008;6(1):35-41.Source linkedPMID
• Batra V, Villgran V. Hyperkalemia from Dietary Supplements. Cureus. 2016;8(11):e859.Source linkedPMID

Recommendation

Avoid activated charcoal supplements while taking digoxin unless a clinician specifically directs it. If a one-time charcoal dose is unavoidable outside an emergency setting, separate it from digoxin by at least 6 hours and tell your prescriber if palpitations, swelling, or shortness of breath worsen.

Mechanism

Activated charcoal nonselectively adsorbs digoxin in the gut, reducing drug available for absorption and potentially interrupting intestinal recirculation. This lowers systemic digoxin exposure when timing overlaps.

• Neuvonen PJ, Kivisto K, Hirvisalo EL. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide. Br J Clin Pharmacol. 1988;25(2):229-233.Source linkedPMID
• Neuvonen PJ, Elfving SM, Elonen E. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur J Clin Pharmacol. 1978;13(3):213-218.Source linkedPMID

Recommendation

Reduce digoxin dose by 50% when starting amiodarone. Monitor digoxin levels closely. Watch for toxicity signs (nausea, visual changes, bradycardia, arrhythmias).

Mechanism

Amiodarone inhibits P-glycoprotein (MDR1)-mediated renal tubular secretion and biliary excretion of digoxin, and reduces its volume of distribution, resulting in approximately doubled digoxin serum levels.

• Fromm MF et al. Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation. 1999.Source linkedPMID

Recommendation

Do not combine berberine with digoxin without prescriber approval. If both are used, monitor for digoxin toxicity and ask your clinician whether a digoxin level is needed after berberine is started or stopped.

Mechanism

Digoxin is a P-glycoprotein substrate. Berberine inhibited intestinal P-glycoprotein in pharmacokinetic studies and increased oral digoxin AUC and Cmax in an animal model, creating a plausible exposure-increase risk in humans.

• Qiu W, Jiang XH, Liu CX, et al. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytotherapy Research. 2009;23(11):1553-1558.Source linkedPMID
• Coumau C, Csajka C. A Systematic Review and Classification of the Effects of P-glycoprotein Inhibitors and Inducers in Humans, Using Digoxin, Fexofenadine, and Dabigatran as Probe Drugs. Clinical Pharmacokinetics. 2025.Source linkedPMID

Recommendation

Do not combine berberine HCl with digoxin without prescriber approval. If both are used, monitor for digoxin toxicity and ask your clinician whether a digoxin level is needed after berberine HCl is started or stopped.

Mechanism

Digoxin is a P-glycoprotein substrate. Berberine inhibited intestinal P-glycoprotein in pharmacokinetic studies and increased oral digoxin AUC and Cmax in an animal model, creating a plausible exposure-increase risk in humans.

• Qiu W, Jiang XH, Liu CX, et al. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytotherapy Research. 2009;23(11):1553-1558.Source linkedPMID
• Coumau C, Csajka C. A Systematic Review and Classification of the Effects of P-glycoprotein Inhibitors and Inducers in Humans, Using Digoxin, Fexofenadine, and Dabigatran as Probe Drugs. Clinical Pharmacokinetics. 2025.Source linkedPMID

Recommendation

Do not take high-dose calcium supplements while on digoxin unless your clinician is monitoring calcium and kidney function. Stay within the prescribed daily elemental calcium target and avoid stacking multiple calcium-containing products. Seek urgent care for fainting, new irregular heartbeat, severe weakness, confusion, or persistent vomiting.

Mechanism

Calcium excess can increase extracellular calcium and promote intracellular calcium overload in cardiac tissue. Digoxin inhibits Na+/K+-ATPase, indirectly increasing intracellular calcium; hypercalcemia can amplify this electrophysiologic vulnerability.

• Vella A, Gerber TC, Hayes DL, Reeder GS. Digoxin, hypercalcaemia, and cardiac conduction. Postgrad Med J. 1999;75(887):554-556.Source linkedPMID
• Picolos MK, Orlander PR. Calcium carbonate toxicity: the updated milk-alkali syndrome; report of 3 cases and review of the literature. Endocr Pract. 2005;11(4):272-280.Source linkedPMID
• Walker MD, Shane E. Hypercalcemia: A Review. JAMA. 2022;328(16):1624-1636.Source linkedPMID

Recommendation

Monitor potassium levels closely while on digoxin. Target serum potassium of 4.0-5.0 mEq/L. Potassium supplementation may be needed, especially if also taking diuretics, but avoid oversupplementation. Discuss with your prescriber.

Mechanism

Digoxin inhibits the Na+/K+-ATPase. Hypokalemia reduces extracellular potassium competition for the ATPase binding site, increasing digoxin binding and toxicity. Hyperkalemia can also increase digoxin displacement from its binding site, leading to unpredictable cardiac effects.

• Smith TW. Digitalis: mechanisms of action and clinical use. N Engl J Med. 1988;318(6):358-365.Source linkedPMID
• Filippini T, Naska A, Kasdagli MI et al.. Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2020.Source linkedPMID
• Behers BJ, Behers BM, Stephenson-Moe CA et al.. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length. Nutrients. 2024.Source linkedPMID
• D'Elia L, Cappuccio FP, Masulli M et al.. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients. 2023.Source linkedPMID

Recommendation

Take psyllium husk at least 4 hours away from digoxin and keep your fiber routine consistent from day to day. Tell your prescriber if you start or stop daily psyllium, because symptoms or digoxin levels may need monitoring.

Mechanism

Gel-forming fiber can trap or adsorb digoxin in the intestinal lumen and change transit, reducing the amount available for absorption. Consistent separation lowers the chance of a clinically meaningful drop in exposure.

• Nordstrom M, Melander A, Robertsson E, Steen B. Influence of wheat bran and of a bulk-forming ispaghula cathartic on the bioavailability of digoxin in geriatric in-patients. Drug Nutr Interact. 1987;5(2):67-69.Source linkedPMID
• Reissell P, Manninen V. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides. Acta Med Scand Suppl. 1982;668:88-90.Source linkedPMID

Recommendation

Do not combine St. John's Wort with digoxin. The reduction in digoxin levels can lead to loss of rate control or worsening heart failure. If already taking both, consult your cardiologist before making changes.

Mechanism

St. John's Wort induces P-glycoprotein (MDR1) expression in the intestine and kidneys. Digoxin is a P-gp substrate, increased intestinal P-gp reduces digoxin absorption, and increased renal P-gp enhances digoxin secretion, together substantially lowering plasma digoxin concentrations.

• Johne A et al. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther. 1999;66(4):338-345.Source linkedPMID

Recommendation

Avoid high-dose vitamin D3 while taking digoxin unless your clinician is monitoring calcium and kidney function. If you need vitamin D repletion, use the prescribed dose and ask when calcium should be rechecked. Seek urgent care for fainting, new irregular heartbeat, severe weakness, confusion, or persistent vomiting.

Mechanism

Vitamin D3 toxicity increases intestinal calcium absorption and can produce hypercalcemia. Hypercalcemia increases myocardial excitability and can potentiate digoxin's sodium-potassium ATPase effects, raising susceptibility to conduction disturbances and arrhythmias.

• Vella A, Gerber TC, Hayes DL, Reeder GS. Digoxin, hypercalcaemia, and cardiac conduction. Postgrad Med J. 1999;75(887):554-556.Source linkedPMID
• Galior K, Grebe S, Singh R. Development of Vitamin D Toxicity from Overcorrection of Vitamin D Deficiency: A Review of Case Reports. Nutrients. 2018;10(8):953.Source linkedPMID
• Holick MF. Vitamin D Is Not as Toxic as Was Once Thought: A Historical and an Up-to-Date Perspective. Mayo Clin Proc. 2015;90(5):561-564.Source linkedPMID

Recommendation

Avoid combining St. John's Wort with diltiazem.

Mechanism

Diltiazem is a CYP3A4 substrate. Hyperforin-mediated CYP3A4 induction increases diltiazem metabolism, reducing its bioavailability and therapeutic effect.

• Moore LB et al. St. John's wort induces hepatic drug metabolism through PXR. Proc Natl Acad Sci USA. 2000;97(13):7500-7502.Source linkedPMID

Recommendation

Do NOT combine without oncologist approval. DIM may reduce tamoxifen effectiveness.

Mechanism

DIM induces CYP1A2 (113-fold) altering tamoxifen metabolism and reducing endoxifen.

• DIM + tamoxifen RCT, reduced endoxifenSource linkedPMID
• DIM induces CYP3A4 via PXRSource linkedPMID

Recommendation

Avoid alcohol when you take diphenhydramine, including nighttime sleep-aid doses. Do not drive, operate machinery, or take extra sedatives if both were used the same day. Seek help for severe confusion, extreme sleepiness, falls, or trouble breathing.

Mechanism

Diphenhydramine crosses the blood-brain barrier and blocks central H1 and muscarinic receptors, causing sedation, slowed reaction time, and impaired attention. Alcohol independently depresses CNS arousal and motor coordination, so the combined pharmacodynamic effect can exceed either substance alone.

• Baugh R, Calvert RT. The effect of diphenhydramine alone and in combination with ethanol on histamine skin response and mental performance. Eur J Clin Pharmacol. 1977;12(3):201-204.Source linkedPMID
• Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000;132(5):354-363.Source linkedPMID

Recommendation

Maintain adequate magnesium intake and ask about magnesium checks if you take diuretics, PPIs, or have gastrointestinal losses. Do not use high-dose magnesium without monitoring if you have kidney disease, and seek urgent care for fainting, near-fainting, or new sustained palpitations.

Mechanism

Dofetilide blocks IKr and prolongs repolarization. Hypomagnesemia promotes electrical instability and early afterdepolarizations; magnesium repletion is part of standard torsades prevention and treatment.

• Jaiswal A, Goldbarg S. Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies. Indian Heart J. 2014;66(6):640-648.Source linkedPMID
• Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139-152.Source linkedPMID

Recommendation

Keep potassium in the normal range and follow your prescriber's lab-monitoring plan, especially during dofetilide initiation, dose changes, illness with vomiting or diarrhea, or diuretic use. Do not start potassium supplements unless your clinician is monitoring your blood level and kidney function.

Mechanism

Dofetilide is a selective IKr blocker. Hypokalemia further suppresses repolarizing potassium current and increases early afterdepolarizations, making torsades more likely.

• Jaiswal A, Goldbarg S. Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies. Indian Heart J. 2014;66(6):640-648.Source linkedPMID
• Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139-152.Source linkedPMID

Recommendation

Take doxycycline at least 2 hours before or 6 hours after any aluminum or magnesium hydroxide antacid. Do not co-administer.

Mechanism

Al3+ and Mg2+ chelate the beta-diketone system of tetracyclines, forming insoluble complexes that are not absorbed across the intestinal epithelium.

• Gugler R, Allgayer H. Effects of antacids on the clinical pharmacokinetics of drugs. An update. Clin Pharmacokinet. 1990;18(3):210-219.Source linkedPMID
• Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929-6932.Source linkedPMID

Recommendation

Separate doxycycline and calcium supplements by at least 2 hours. Avoid dairy products (high calcium) within 2 hours of doxycycline dosing. Take doxycycline with water between meals for optimal absorption.

Mechanism

Calcium ions chelate doxycycline's beta-diketone system and adjacent hydroxyl groups, forming insoluble calcium-tetracycline complexes. These complexes are too large and insoluble for intestinal absorption and are excreted in feces.

• Leyden JJ. Absorption of minocycline hydrochloride and tetracycline hydrochloride: effect of food, milk, and iron. J Am Acad Dermatol. 1985;12(2 Pt 1):308-312.Source linkedPMID
• Liu C, Kuang X, Li K, Guo X, Deng Q, Li D. Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. Food & Function. 2020.Source linkedPMID
• Yao P, Bennett D, Mafham M et al.. Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-analysis. JAMA Network Open. 2019.Source linkedPMID

Recommendation

Take doxycycline at least 2 hours before or 6 hours after calcium carbonate. Do not co-administer.

Mechanism

Ca2+ chelates the beta-diketone system of tetracyclines, forming insoluble complexes that block intestinal absorption.

• Gugler R, Allgayer H. Effects of antacids on the clinical pharmacokinetics of drugs. An update. Clin Pharmacokinet. 1990;18(3):210-219.Source linkedPMID
• Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929-6932.Source linkedPMID

Recommendation

Separate doxycycline and iron supplements by at least 2 hours. Take doxycycline at least 2 hours before or after iron to ensure adequate antibiotic absorption and treatment efficacy.

Mechanism

Iron (Fe2+ and Fe3+) chelates doxycycline through its hydroxyl and keto groups, forming insoluble iron-tetracycline complexes. Iron is a particularly strong chelator of tetracyclines, producing very stable complexes with minimal dissociation.

• Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs. 1976;11(1):45-54.Source linkedPMID
• Fischer JAJ, Cherian AM, Bone JN, Karakochuk CD. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews. 2023.Source linkedPMID
• Rehman T, Agrawal R, Ahamed F et al.. Optimal dose and duration of iron supplementation for treating iron deficiency anaemia in children and adolescents: A systematic review and meta-analysis. PLoS One. 2025.Source linkedPMID
• Gutema BT, Sorrie MB, Megersa ND et al.. Effects of iron supplementation on cognitive development in school-age children: Systematic review and meta-analysis. PLoS One. 2023.Source linkedPMID

Recommendation

Take doxycycline at least 2 hours before or 6 hours after iron bisglycinate. Do not take in the same dose.

Mechanism

Iron chelates the beta-diketone system of tetracyclines, forming insoluble complexes that are not absorbed. Doxycycline also re-enters the gut via enterohepatic recirculation, where iron can re-chelate it.

• Neuvonen PJ, Penttilä O. Effect of oral ferrous sulphate on the half-life of doxycycline in man. Eur J Clin Pharmacol. 1974;7(5):361-3.Source linkedPMID
• Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions. Br J Clin Pharmacol. 1991;31(3):251-5.Source linkedPMID

Recommendation

Take doxycycline at least 2 hours before or 6 hours after magnesium citrate. Do not co-administer.

Mechanism

Mg2+ from magnesium citrate chelates the beta-diketone system of tetracyclines, forming insoluble complexes that block intestinal absorption.

• Gugler R, Allgayer H. Effects of antacids on the clinical pharmacokinetics of drugs. An update. Clin Pharmacokinet. 1990;18(3):210-219.Source linkedPMID
• Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929-6932.Source linkedPMID

Recommendation

Separate doxycycline and magnesium supplements by at least 2 hours. This includes magnesium-containing antacids and laxatives. Take doxycycline with water on an empty stomach when possible.

Mechanism

Magnesium divalent cations chelate doxycycline via its multiple hydroxyl and keto groups, forming poorly soluble magnesium-tetracycline complexes that resist intestinal absorption.

• Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs. 1976;11(1):45-54.Source linkedPMID
• Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis.. BMC Complementary Medicine and Therapies. 2021.Source linkedPMID
• Veronese N, Dominguez LJ, Pizzol D et al.. Oral Magnesium Supplementation for Treating Glucose Metabolism Parameters in People with or at Risk of Diabetes: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.. Nutrients. 2021.Source linkedPMID
• Veronese N, Pizzol D, Smith L et al.. Effect of Magnesium Supplementation on Inflammatory Parameters: A Meta-Analysis of Randomized Controlled Trials.. Nutrients. 2022.Source linkedPMID

Recommendation

Avoid high-dose vitamin A supplements while taking doxycycline. Standard food intake and ordinary multivitamin doses are usually not the issue, but avoid retinol-heavy products unless your clinician approves them. Stop the supplement and seek urgent evaluation for severe headache, blurred vision, double vision, or ringing in the ears.

Mechanism

Tetracyclines can impair cerebrospinal fluid dynamics and have been repeatedly linked to drug-induced intracranial hypertension. Vitamin A excess and retinoids are also linked to intracranial hypertension, so the combination creates additive risk rather than a timing-sensitive absorption problem.

• Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6(1):29-37.Source linkedPMID
• Quinn AG, Singer SB, Buncic JR. Pediatric tetracycline-induced pseudotumor cerbri. J AAPOS. 1999;3(1):53-57.Source linkedPMID
• Jacobson DM, Berg R, Wall M, Digre KB, Corbett JJ, Ellefson RD. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology. 1999;53(5):1114-1118.Source linkedPMID
• Walters BN, Gubbay SS. Tetracycline and benign intracranial hypertension: report of five cases. Br Med J (Clin Res Ed). 1981;282(6257):19-20.Source linkedPMID

Recommendation

Take doxycycline at least 2 hours before or 6 hours after zinc carnosine. Do not co-administer.

Mechanism

Zn2+ from zinc carnosine chelates the beta-diketone system of tetracyclines, forming insoluble complexes that block intestinal absorption.

• Mapp RK, McCarthy TJ. The effect of zinc sulphate and of bicitropeptide on tetracycline absorption. S Afr Med J. 1976;50(45):1829-30.Source linkedPMID
• Weismann K. Chelating drugs and zinc. Dan Med Bull. 1986;33(4):208-11.Source linkedPMID

Recommendation

Take doxycycline at least 2 hours before or 6 hours after zinc picolinate. Do not co-administer.

Mechanism

Zn2+ chelates the beta-diketone system of tetracyclines, forming insoluble complexes in the intestinal lumen that are not absorbed.

• Mapp RK, McCarthy TJ. The effect of zinc sulphate and of bicitropeptide on tetracycline absorption. S Afr Med J. 1976;50(45):1829-30.Source linkedPMID
• Weismann K. Chelating drugs and zinc. Dan Med Bull. 1986;33(4):208-11.Source linkedPMID

Recommendation

Same precautions as other GLP-1 agonists. Monitor glucose and watch for excessive GI symptoms.

Mechanism

Dulaglutide activates GLP-1 receptors (weekly dosing). Berberine activates AMPK. Additive glucose lowering and GI slowing.

• Gerstein HC et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND). Lancet. 2019;394(10193):121-130.Source linkedPMID
• Asbaghi O, Ghanbari N, Shekari M et al.. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.. Clinical Nutrition ESPEN. 2020.Source linkedPMID

Recommendation

Do not combine 5-HTP with duloxetine. The risk of serotonin syndrome is significant with this combination. If you are taking 5-HTP, discontinue it and inform your prescriber before starting any SNRI.

Mechanism

Duloxetine blocks both SERT and NET, increasing synaptic serotonin and norepinephrine. 5-HTP bypasses the rate-limiting tryptophan hydroxylase step to directly increase serotonin synthesis. Combined increased production and decreased reuptake can trigger serotonin syndrome.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Truyens M, Lobatón T, Ferrante M et al.. Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial. Gastroenterology. 2022.Source linkedPMID
• Sutanto CN, Xia X, Heng CW et al.. The impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: A randomized controlled trial. Clinical Nutrition. 2024.Source linkedPMID

Recommendation

Avoid heavy alcohol use while taking duloxetine. If you have alcohol use disorder, chronic liver disease, or abnormal liver tests, ask your prescriber about a different medication before starting duloxetine. Seek prompt medical care for jaundice, dark urine, severe right upper abdominal pain, or unexplained severe fatigue.

Mechanism

Duloxetine undergoes hepatic metabolism mainly through CYP1A2 and CYP2D6 and can rarely cause idiosyncratic hepatocellular or cholestatic injury. Alcohol adds hepatic stress and can create underlying liver disease, reducing reserve if duloxetine-associated injury occurs.

• Vuppalanchi R, Hayashi PH, Chalasani N, et al. Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network. Aliment Pharmacol Ther. 2010;32(9):1174-1183.Source linkedPMID
• Wohlreich MM, Acharya N, Strombom I, et al. Answers to the most common questions about the hepatic safety profile of duloxetine. Postgrad Med. 2008;120(2):111-118.Source linkedPMID

Recommendation

Avoid starting SAMe with duloxetine unless the prescriber managing duloxetine approves and monitors the combination. Seek urgent care for clonus, high fever, severe agitation, confusion, or seizure.

Mechanism

Duloxetine inhibits serotonin and norepinephrine reuptake. SAMe participates in methylation pathways relevant to monoamine metabolism and has clinical antidepressant activity, creating additive serotonergic and mood-activating potential.

• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.Source linkedPMID
• Iruela LM, Minguez L, Merino J, Monedero G. Toxic interaction of S-adenosylmethionine and clomipramine. Am J Psychiatry. 1993;150(3):522.Source linkedPMID

Recommendation

If supplementing elderberry zinc lozenges >25mg daily, add 1-2mg copper. Many elderberry zinc lozenges supplements include copper for this reason. Monitor copper status.

Mechanism

Elderberry Zinc Lozenges induces metallothionein in intestinal cells, which preferentially binds copper, trapping it in enterocytes that are later shed, causing copper loss.

• Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51(2):225-7.Source linkedPMID
• Hoffman HN 2nd et al. Zinc-induced copper deficiency. Gastroenterology. 1988;94(2):508-12.Source linkedPMID
• Jaiser SR et al. Copper deficiency myelopathy. J Neurol. 2010;257(6):869-81.Source linkedPMID

Recommendation

Avoid Lithium Orotate while taking enalapril. If you must use it, keep the dose low, stay well hydrated, and ask your prescriber to check a serum lithium level after a week or two. Hold lithium during any vomiting, diarrhea, or fever illness.

Mechanism

ACE inhibition reduces angiotensin II and aldosterone, causing natriuresis and a fall in GFR. Lithium is reabsorbed in the proximal tubule in parallel with sodium, so sodium loss and reduced filtration both increase fractional lithium reabsorption.

• DasGupta K, Jefferson JW, Kobak KA, Greist JH. The effect of enalapril on serum lithium levels in healthy men. J Clin Psychiatry. 1992;53(11):398-400.Source linkedPMID
• Finley PR, O'Brien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol. 1996;16(1):68-71.Source linkedPMID

Recommendation

Avoid potassium supplements on enalapril unless prescribed with monitoring. Avoid potassium salt substitutes.

Mechanism

ACE inhibition reduces angiotensin II and aldosterone. Reduced aldosterone means less renal potassium excretion via ENaC/ROMK in the collecting duct.

• Palmer BF. Managing hyperkalemia caused by RAAS inhibitors. N Engl J Med. 2004;351(6):585-592.Source linkedPMID
• Filippini T, Naska A, Kasdagli MI et al.. Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2020.Source linkedPMID
• Behers BJ, Behers BM, Stephenson-Moe CA et al.. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length. Nutrients. 2024.Source linkedPMID
• D'Elia L, Cappuccio FP, Masulli M et al.. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients. 2023.Source linkedPMID

Recommendation

Avoid ginkgo biloba while on enoxaparin. If you have been combining them, stop the ginkgo and call your prescriber if you notice unusual bruising, nosebleeds, or any sign of bleeding.

Mechanism

Ginkgolides (notably ginkgolide B) are PAF antagonists that inhibit platelet aggregation and prolong bleeding time. This pharmacodynamic effect adds to enoxaparin's anti-factor Xa activity.

• Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657-61.Source linkedPMID
• Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490-502.Source linkedPMID

Recommendation

Avoid potassium supplements and potassium-based salt substitutes while on enoxaparin unless prescribed and monitored. If you must take potassium, ask for serum potassium to be checked within 3-5 days of starting enoxaparin and weekly thereafter.

Mechanism

Heparins (unfractionated and LMWH) reduce adrenal cortex aldosterone synthesis by inhibiting angiotensin II receptor signaling in the zona glomerulosa. Reduced aldosterone lowers renal potassium excretion, raising serum potassium. Effects are dose- and duration-dependent and worse with renal impairment.

• Koren-Michowitz M, Avni B, Michowitz Y, Moravski G, Efrati S, Golik A. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study. Pharmacoepidemiol Drug Saf. 2004;13(5):299-302.Source linkedPMID
• Amdetsion GY, Gudeta A, Lumley G, Sagoo H, Aliledhin E. Heparin-induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review. EJHaem. 2023;4(4):1110-1116.Source linkedPMID

Recommendation

Do not combine 5-HTP with escitalopram. If you are currently using both, discontinue 5-HTP and inform your prescriber.

Mechanism

5-HTP is decarboxylated to serotonin by AADC, increasing serotonin synthesis. Escitalopram is the most selective SERT inhibitor, maximizing synaptic serotonin retention. Combined increased production and decreased clearance can trigger serotonin syndrome.

• Birdsall TC. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev. 1998;3(4):271-280.Source linkedPMID
• Truyens M, Lobatón T, Ferrante M et al.. Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial. Gastroenterology. 2022.Source linkedPMID
• Sutanto CN, Xia X, Heng CW et al.. The impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: A randomized controlled trial. Clinical Nutrition. 2024.Source linkedPMID

Recommendation

Avoid supplemental L-tryptophan while taking escitalopram. If you wish to support mood through diet, discuss safe options with your prescriber.

Mechanism

L-Tryptophan increases serotonin synthesis by providing additional substrate for tryptophan hydroxylase. Escitalopram's potent and selective SERT inhibition prevents clearance of the excess serotonin from the synaptic cleft, creating risk of serotonergic toxicity.

• Steiner W, Fontaine R. Toxic reaction following the combined administration of fluoxetine and L-tryptophan. Biol Psychiatry. 1986;21(11):1067-1071.Source linkedPMID

Recommendation

Only combine SAMe with escitalopram under direct psychiatric supervision. Do not add SAMe on your own. Start at low doses if prescribed together, and monitor for signs of serotonin excess.

Mechanism

SAMe enhances serotonin synthesis and turnover through methylation reactions and increases postsynaptic serotonin receptor sensitivity. Combined with escitalopram's selective SERT inhibition, synaptic serotonin levels can rise excessively.

• Papakostas GI et al. S-adenosyl-methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders. Am J Psychiatry. 2010;167(8):942-948.Source linkedPMID
• Amenyah SD, Hughes CF, Ward M, Rosborough S, Deane J, Thursby SJ et al.. Influence of nutrients involved in one-carbon metabolism on DNA methylation in adults-a systematic review and meta-analysis.. Nutrition Reviews. 2020.Source linkedPMID

Recommendation

If you take esomeprazole for more than a year, ask your prescriber to check serum magnesium periodically. If levels are low, a daily magnesium glycinate supplement is reasonable, but persistent or symptomatic hypomagnesemia usually requires stopping the PPI to fully resolve.

Mechanism

Prolonged acid suppression appears to impair active magnesium uptake in the small intestine via TRPM6/TRPM7 channels, which depend on luminal proton gradients. The defect reverses within days of stopping the PPI and recurs on rechallenge.

• Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther. 2012;36(5):405-13.Source linkedPMID
• Park CH, Kim EH, Roh YH, Kim HY, Lee SK. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PLoS One. 2014;9(11):e112558.Source linkedPMID
• Hoorn EJ, van der Hoek J, de Man RA, et al. A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis. 2010;56(1):112-6.Source linkedPMID